"Categories","Diseases or Functions Annotation","p-value","Molecules","# Molecules"
"Psychological Disorders","Tobacco-related disorder",4.76e-08,"CA6,CA9,CHRNA9,CYP2A6 (includes others),DDC,GABBR2,GABRP,OPRK1,SCN1A",9
"Cell Morphology","Keratinization",3.71e-07,"CASP14,KRT20,KRT34,KRT38,KRT6C,KRT75,KRT81,KRT83,KRT85,PI3,SPRR1A,SPRR2D",12
"Lipid Metabolism,Small Molecule Biochemistry","Conjugation of 12-hydroxyeicosatetraenoic acid",5.32e-07,"UGT1A9 (includes others),UGT2B10,UGT2B11,UGT2B4",4
"Cell Morphology,Embryonic Development,Hair and Skin Development and Function,Organ Development,Organismal Development,Tissue Development","Keratinization of epidermis",1.5e-05,"CASP14,KRT20,KRT34,KRT38,KRT6C,KRT75,KRT81,KRT83,KRT85",9
"Cancer,Organismal Injury and Abnormalities,Respiratory Disease","Malignant neoplasm of respiratory system",1.65e-05,"A2ML1,ACE2,ACTL8,ACTN2,AFAP1-AS1,C18orf63,C1orf94,CA9,CALCB,CCKBR,CDH1,CDH19,CHGA,CHRDL2,CT83,CYP24A1,CYP27C1,CYP2A6 (includes others),DDC,DIO1,DLK1,DLX6,DMRT1,DNER,EN1,FBN3,FETUB,FGA,FGB,FZD9,GABRP,GLDC,HAO1,HRCT1,IL36A,KCNQ2,KCNV1,KIF1A,KLHL1,KRT20,KRT38,KRT6C,KRT81,LACRT,LCT,LIN28B,LINC00261,LUZP4,LY6D,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB4,MMP1,MSLN,MUC21,NETO1,NKX2-1,NR2E1,OPRK1,PADI3,PCDH11X,PCDH8,PGBD5,POU4F1,PRAME,PXDNL,RAET1L,RCOR2,RGR,SCN1A,SFTPC,SH3GL3,SLC12A1,SLC15A1,SLC26A9,SLC28A1,SLC39A12,SLIT1,SMR3A,SOX11,SPANXB1 (includes others),STRA8,SULT1C3,TAFA4,TBXT,TCERG1L,TMPRSS4,UGT1A6,UGT1A9 (includes others),UGT2B10,UGT2B11,UGT2B4,ZFP42,ZP4",96
"Cancer,Organismal Injury and Abnormalities","Malignant soft tissue neoplasm",2.89e-05,"A2ML1,ACE2,ACTL8,ACTN2,AMTN,ANKRD1,ART3,BPI,C18orf63,C1orf94,CA6,CASP14,CCKBR,CCL7,CDH1,CDK5R2,CELF4,CHODL,CHRDL2,CHRNA9,CLDN6,COL9A3,CP,CPB1,CRABP1,CRISP3,CRNN,CT83,CYP24A1,CYP2A6 (includes others),CYP2F1,DCD,DDC,DHRS2,DLK1,DLX6,DMRT1,DNER,ELF5,EN1,FABP7,FADS2,FBN3,FETUB,FGA,FGB,FOXA2,GABBR2,GABRP,GGTLC2,GLDC,GNAT3,HAO1,HCN4,HORMAD1,HRCT1,IL36A,INA,KCNE5,KCNQ2,KCNV1,KIF1A,KLHL1,KLHL34,KRT20,KRT34,KRT6C,KRT75,KRT81,KRT83,KRT85,LACRT,LBP,LCT,LEMD1,LIN28B,LY6D,MAGEA3/MAGEA6,MAGEA4,MAGEB1,MAGEB4,MMP1,MSLN,MUC21,NETO1,NR2E1,OPRK1,PADI3,PCDH11X,PCDH8,PGBD5,PI3,PPP1R14C,PRAME,PRDM13,PRKAG3,PROKR2,PRR27,PRSS3,PRSS33,PSAPL1,PXDNL,RAB3B,S100A2,S100A8,SCN1A,SFTA3,SH3GL3,SLC12A1,SLC15A1,SLC1A6,SLC26A9,SLC28A1,SLC39A12,SLC6A17,SLIT1,SMC1B,SMOC1,SMR3A,SOST,SOX11,SPANXB1 (includes others),SPDYC,SPRR1A,SPRR2D,STRA8,SULT1C3,TAFA4,TBXT,TMPRSS4,TRIM15,UBD,UGT1A6,UGT1A9 (includes others),UGT2A3,UGT2B10,UGT2B11,UGT2B28,UGT2B4,VGLL1,WNT6,ZFP42,ZNF280A,ZP4",144
"Cancer,Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Skin cancer",3.13e-05,"A2ML1,ACE2,ACTL8,ACTN2,AMTN,ANKRD1,ART3,BARHL2,BPI,C18orf63,C1orf94,CA6,CASP14,CCKBR,CCL7,CDH1,CDH19,CDK5R2,CELF4,CHODL,CHRDL2,CHRNA9,CLDN6,COL9A3,CP,CPB1,CRABP1,CRISP3,CRNN,CT83,CXCL10,CYP24A1,CYP27C1,CYP2A6 (includes others),CYP2F1,DCD,DDC,DHRS2,DLK1,DLX6,DMRT1,DNER,ELF5,EN1,FADS2,FBN3,FETUB,FGA,FGB,FOXA2,FZD9,GABBR2,GABRP,GGTLC2,GLDC,GNAT3,GNGT1,HAO1,HCN4,HORMAD1,HRCT1,IL36A,INA,KCNE5,KCNQ2,KCNV1,KIF1A,KLHL1,KLHL34,KRT20,KRT34,KRT38,KRT6C,KRT75,KRT81,KRT83,KRT85,LACRT,LBP,LCT,LEMD1,LIN28B,LY6D,MAGEA3/MAGEA6,MAGEA4,MAGEB1,MAGEB4,MMP1,MSLN,MUC21,NETO1,NR2E1,OPRK1,PADI3,PCDH11X,PCDH8,PGBD5,PI3,PPP1R14C,PRAME,PRDM13,PRKAG3,PROKR2,PRR27,PRSS3,PRSS33,PSAPL1,PXDNL,RAB3B,S100A8,SCN1A,SFTA3,SH3GL3,SLC12A1,SLC15A1,SLC1A6,SLC26A9,SLC28A1,SLC39A12,SLC6A17,SLIT1,SMC1B,SMOC1,SMR3A,SOST,SOX11,SPANXB1 (includes others),SPDYC,SPRR1A,SPRR2D,STRA8,SULT1C3,TAFA4,TBXT,TMPRSS4,TRIM15,UBD,UGT1A6,UGT1A9 (includes others),UGT2A3,UGT2B10,UGT2B11,UGT2B28,UGT2B4,VGLL1,ZFP42,ZNF280A,ZP4",148
"Psychological Disorders","Drug dependence",3.17e-05,"CA6,CA9,CARTPT,CHRNA9,DDC,GABBR2,GABRP,OPRK1,SCN1A",9
"Cancer,Organismal Injury and Abnormalities","Malignant connective or soft tissue neoplasm",3.23e-05,"A2ML1,ACE2,ACTL8,ACTN2,AMTN,ANKRD1,ART3,BPI,C18orf63,C1orf94,CA6,CALCB,CASP14,CCKBR,CCL7,CDH1,CDK5R2,CELF4,CHODL,CHRDL2,CHRNA9,CLDN6,COL9A3,CP,CPB1,CRABP1,CRISP3,CRNN,CT83,CYP24A1,CYP2A6 (includes others),CYP2F1,DCD,DDC,DHRS2,DLK1,DLX6,DMRT1,DNER,ELF5,EN1,FABP7,FADS2,FBN3,FETUB,FGA,FGB,FOXA2,GABBR2,GABRP,GGTLC2,GLDC,GNAT3,HAO1,HCN4,HORMAD1,HRCT1,IL36A,INA,KCNE5,KCNQ2,KCNV1,KIF1A,KLHL1,KLHL34,KRT20,KRT34,KRT6C,KRT75,KRT81,KRT83,KRT85,LACRT,LBP,LCT,LEMD1,LIN28B,LY6D,MAGEA3/MAGEA6,MAGEA4,MAGEB1,MAGEB4,MMP1,MSLN,MUC21,NETO1,NR2E1,OPRK1,PADI3,PCDH11X,PCDH8,PGBD5,PI3,PPP1R14C,PRAME,PRDM13,PRKAG3,PROKR2,PRR27,PRSS3,PRSS33,PSAPL1,PXDNL,RAB3B,S100A2,S100A8,SCN1A,SFTA3,SH3GL3,SLC12A1,SLC15A1,SLC1A6,SLC26A9,SLC28A1,SLC39A12,SLC6A17,SLIT1,SMC1B,SMOC1,SMR3A,SOST,SOX11,SPANXB1 (includes others),SPDYC,SPRR1A,SPRR2D,STRA8,SULT1C3,TAFA4,TBXT,TMPRSS4,TRIM15,UBD,UGT1A6,UGT1A9 (includes others),UGT2A3,UGT2B10,UGT2B11,UGT2B28,UGT2B4,VGLL1,WNT6,ZFP42,ZNF280A,ZP4",145
"Psychological Disorders","Compulsive gambling",3.37e-05,"CA6,CA9,OPRK1,SCN1A",4
"Psychological Disorders","Impulse control disorder",3.48e-05,"CA6,CA9,DDC,GABRP,OPRK1,SCN1A",6
"Cardiovascular Disease,Organismal Injury and Abnormalities","Abnormality of heart ventricle",4.08e-05,"ACE2,ACTN2,ANKRD1,CA6,CA9,GABRP,HCN4,MMP1,OPRK1,SLC12A1",10
"Cardiovascular Disease,Organismal Injury and Abnormalities","Abnormality of left ventricle",4.18e-05,"ACE2,ACTN2,ANKRD1,CA6,CA9,GABRP,HCN4,MMP1,SLC12A1",9
"Cancer,Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Cutaneous melanoma",4.86e-05,"A2ML1,ACE2,ACTL8,ACTN2,AMTN,ANKRD1,ART3,BPI,C18orf63,C1orf94,CA6,CASP14,CCKBR,CCL7,CDK5R2,CELF4,CHODL,CHRDL2,CHRNA9,CLDN6,COL9A3,CP,CPB1,CRABP1,CRISP3,CRNN,CT83,CYP24A1,CYP2A6 (includes others),CYP2F1,DCD,DDC,DHRS2,DLK1,DLX6,DMRT1,DNER,ELF5,EN1,FADS2,FBN3,FETUB,FGA,FGB,FOXA2,GABBR2,GABRP,GGTLC2,GLDC,GNAT3,HAO1,HCN4,HORMAD1,IL36A,INA,KCNE5,KCNQ2,KCNV1,KIF1A,KLHL1,KLHL34,KRT20,KRT34,KRT6C,KRT75,KRT81,KRT83,KRT85,LACRT,LBP,LCT,LEMD1,LIN28B,LY6D,MAGEA3/MAGEA6,MAGEA4,MAGEB1,MAGEB4,MMP1,MSLN,MUC21,NETO1,NR2E1,OPRK1,PADI3,PCDH11X,PCDH8,PGBD5,PI3,PPP1R14C,PRAME,PRDM13,PRKAG3,PROKR2,PRR27,PRSS3,PRSS33,PSAPL1,PXDNL,RAB3B,S100A8,SCN1A,SFTA3,SH3GL3,SLC12A1,SLC15A1,SLC1A6,SLC26A9,SLC28A1,SLC39A12,SLC6A17,SLIT1,SMC1B,SMOC1,SMR3A,SOST,SOX11,SPANXB1 (includes others),SPDYC,SPRR1A,SPRR2D,STRA8,SULT1C3,TAFA4,TBXT,TMPRSS4,TRIM15,UBD,UGT1A6,UGT1A9 (includes others),UGT2A3,UGT2B10,UGT2B11,UGT2B28,UGT2B4,VGLL1,ZFP42,ZNF280A,ZP4",139
"Cancer,Organismal Injury and Abnormalities,Respiratory Disease","Lung cancer",5.04e-05,"A2ML1,ACE2,ACTN2,AFAP1-AS1,C18orf63,C1orf94,CA9,CALCB,CCKBR,CDH1,CDH19,CHGA,CHRDL2,CT83,CYP24A1,CYP27C1,CYP2A6 (includes others),DDC,DIO1,DLK1,DLX6,DMRT1,DNER,EN1,FBN3,FETUB,FGA,FGB,FZD9,GABRP,GLDC,HAO1,HRCT1,IL36A,KCNQ2,KCNV1,KIF1A,KLHL1,KRT20,KRT38,KRT6C,LACRT,LCT,LIN28B,LINC00261,LUZP4,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB4,MMP1,MUC21,NETO1,NKX2-1,NR2E1,OPRK1,PCDH11X,PCDH8,PGBD5,POU4F1,PRAME,PXDNL,RAET1L,RCOR2,RGR,SCN1A,SFTPC,SH3GL3,SLC12A1,SLC26A9,SLC28A1,SLC39A12,SLIT1,SMR3A,SPANXB1 (includes others),STRA8,SULT1C3,TAFA4,TBXT,TMPRSS4,UGT1A6,UGT1A9 (includes others),UGT2B10,UGT2B11,ZFP42,ZP4",87
"Dermatological Diseases and Conditions,Neurological Disease,Organismal Injury and Abnormalities","Hyperalgesia",5.84e-05,"CA6,CA9,GABRP,OPRK1,SCN1A",5
"Neurological Disease,Psychological Disorders","Restless legs syndrome",5.84e-05,"CA6,CA9,DDC,OPRK1,SCN1A",5
"Cancer,Organismal Injury and Abnormalities,Respiratory Disease","Lung carcinoma",5.94e-05,"A2ML1,ACE2,ACTN2,AFAP1-AS1,C18orf63,C1orf94,CA9,CALCB,CCKBR,CDH1,CDH19,CHGA,CHRDL2,CT83,CYP24A1,CYP27C1,DDC,DIO1,DLK1,DLX6,DMRT1,DNER,EN1,FBN3,FETUB,FGA,FGB,FZD9,GABRP,GLDC,HAO1,HRCT1,IL36A,KCNQ2,KCNV1,KIF1A,KLHL1,KRT20,KRT38,KRT6C,LACRT,LCT,LIN28B,LINC00261,LUZP4,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB4,MMP1,MUC21,NETO1,NKX2-1,NR2E1,OPRK1,PCDH11X,PCDH8,PGBD5,POU4F1,PRAME,PXDNL,RAET1L,RCOR2,RGR,SCN1A,SH3GL3,SLC12A1,SLC26A9,SLC28A1,SLC39A12,SLIT1,SMR3A,SPANXB1 (includes others),STRA8,SULT1C3,TAFA4,TBXT,TMPRSS4,UGT1A6,UGT1A9 (includes others),UGT2B10,UGT2B11,ZFP42,ZP4",85
"Cancer,Organismal Injury and Abnormalities","Melanoma",6.04e-05,"A2ML1,ACE2,ACTL8,ACTN2,AMTN,ANKRD1,ART3,BPI,C18orf63,C1orf94,CA6,CASP14,CCKBR,CCL7,CDH1,CDH19,CDK5R2,CELF4,CHODL,CHRDL2,CHRNA9,CLDN6,COL9A3,CP,CPB1,CRABP1,CRISP3,CRNN,CT83,CYP24A1,CYP2A6 (includes others),CYP2F1,DCD,DDC,DHRS2,DLK1,DLX6,DMRT1,DNER,ELF5,EN1,FADS2,FBN3,FETUB,FGA,FGB,FOXA2,FZD9,GABBR2,GABRP,GGTLC2,GLDC,GNAT3,HAO1,HCN4,HORMAD1,HRCT1,IL36A,INA,KCNE5,KCNQ2,KCNV1,KIF1A,KLHL1,KLHL34,KRT20,KRT34,KRT6C,KRT75,KRT81,KRT83,KRT85,LACRT,LBP,LCT,LEMD1,LIN28B,LY6D,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEB1,MAGEB4,MMP1,MSLN,MUC21,NETO1,NR2E1,OPRK1,PADI3,PCDH11X,PCDH8,PGBD5,PI3,PPDPFL,PPP1R14C,PRAME,PRDM13,PRKAG3,PROKR2,PRR27,PRSS3,PRSS33,PSAPL1,PXDNL,RAB3B,RLBP1,S100A2,S100A8,SCN1A,SFTA3,SFTPC,SH3GL3,SLC12A1,SLC15A1,SLC1A6,SLC26A9,SLC28A1,SLC39A12,SLC6A17,SLIT1,SMC1B,SMOC1,SMR3A,SOST,SOX11,SPANXB1 (includes others),SPDYC,SPRR1A,SPRR2D,STRA8,SULT1C3,SVOP,TAFA4,TBXT,TMPRSS4,TRIM15,UBD,UGT1A6,UGT1A9 (includes others),UGT2A3,UGT2B10,UGT2B11,UGT2B28,UGT2B4,VGLL1,ZFP42,ZNF280A,ZP4",149
"Psychological Disorders","Alcoholism",6.1e-05,"CA6,CA9,CARTPT,CHRNA9,GABBR2,GABRP,OPRK1,SCN1A",8
"Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Disorder of hair",6.1e-05,"A2ML1,CXCL10,KRT75,KRT81,KRT83,KRT85,PADI3,S100A8",8
"Dermatological Diseases and Conditions,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Nail and hair disorder",6.75e-05,"KRT81,KRT83,KRT85",3
"Psychological Disorders","Depressive disorder",7.08e-05,"CA6,CA9,CARTPT,CCKBR,CHGA,CHRNA9,CXCL10,DDC,GABRP,GAL,OPRK1,SCN1A,SLC1A6",13
"Cardiovascular Disease,Organismal Injury and Abnormalities","Valvulopathy",7.08e-05,"ACE2,ACTN2,CA6,CA9,GABRP,MMP1,OPRK1,SLC12A1",8
"Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders","Cocaine dependence",9.88e-05,"CA6,CA9,CARTPT,OPRK1,SCN1A",5
"Neurological Disease","Sensory disorders",0.000138,"CA6,CA9,GABRP,OPRK1,PROKR2,SCN1A",6
"Psychological Disorders","Mood Disorders",0.00021,"CA6,CA9,CARTPT,CCKBR,CHGA,CHRNA9,CXCL10,DDC,FADS2,GABRP,GAL,GLDC,OPRK1,SCN1A,SLC1A6,STRA8",16
"Organismal Injury and Abnormalities,Respiratory Disease","Chronic obstructive pulmonary disease",0.000219,"CA6,CA9,CHRNA9,CYP2A6 (includes others),GABRP,LBP,MMP1,NKX2-1,OPRK1",9
"Cardiovascular Disease,Organismal Injury and Abnormalities","Aortic valve disease",0.000258,"ACE2,CA6,CA9,GABRP,MMP1,SLC12A1",6
"Developmental Disorder,Hematological Disease,Hereditary Disorder,Immunological Disease,Organismal Injury and Abnormalities","Autosomal recessive congenital afibrinogenemia",0.000266,"FGA,FGB",2
"Developmental Disorder,Hematological Disease,Hereditary Disorder,Immunological Disease,Organismal Injury and Abnormalities","Congenital dysfibrinogenemia",0.000266,"FGA,FGB",2
"Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Autosomal dominant monilethrix",0.000266,"KRT81,KRT83",2
"Lipid Metabolism,Small Molecule Biochemistry","Conjugation of 5-hydroxyeicosatetraenoic acid",0.000266,"UGT1A9 (includes others),UGT2B4",2
"Cellular Development,Embryonic Development,Organ Development,Organismal Development,Reproductive System Development and Function,Tissue Development","Differentiation of mammary gland",0.000266,"EN1,FABP7",2
"Embryonic Development,Hair and Skin Development and Function,Organ Development,Organismal Development,Tissue Development","Formation of skin",0.000335,"CASP14,CDH1,KRT20,KRT34,KRT38,KRT6C,KRT75,KRT81,KRT83,KRT85,SPRR1A",11
"Neurological Disease,Organismal Injury and Abnormalities","Focal generalized tonic clonic epilepsy",0.000351,"CA6,CA9,SCN1A",3
"Psychological Disorders","Nicotine dependence",0.000352,"CA6,CA9,CHRNA9,GABRP,SCN1A",5
"Drug Metabolism","Metabolism of xenobiotic",0.000403,"CYP2A6 (includes others),CYP2F1,SULT1C3,UGT1A6,UGT1A9 (includes others),UGT2B11",6
"Nutritional Disease,Psychological Disorders","Binge eating disorder",0.000404,"CA6,CA9,OPRK1,SCN1A",4
"Neurological Disease,Organismal Injury and Abnormalities","Basilar-type migraine",0.000429,"CA6,CA9,SCN1A",3
"Organismal Injury and Abnormalities,Psychological Disorders","Primary anxiety disorder",0.000429,"CA6,CA9,SCN1A",3
"Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities,Respiratory Disease","Small cell lung carcinoma",0.000445,"C18orf63,C1orf94,CALCB,CCKBR,CDH19,CHGA,CHRDL2,CT83,DDC,DLX6,DNER,FBN3,FETUB,FGA,FZD9,GLDC,HRCT1,IL36A,KLHL1,LACRT,LCT,LUZP4,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB4,NETO1,NKX2-1,NR2E1,OPRK1,PCDH11X,PGBD5,PXDNL,RGR,SCN1A,SH3GL3,SLC12A1,SLC26A9,SLIT1,SMR3A,STRA8,SULT1C3,TAFA4,TBXT,TMPRSS4,UGT1A6,UGT1A9 (includes others),UGT2B10,ZP4",50
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Tourette syndrome",0.000467,"CA6,CA9,OPRK1,SCN1A,SLC1A6",5
"Organismal Injury and Abnormalities,Respiratory Disease","Edema of lung",0.000496,"CA6,CA9,GABRP,SLC12A1",4
"Cardiovascular Disease,Organismal Injury and Abnormalities,Respiratory Disease","Pulmonary vascular disease",0.000514,"ANKRD1,CA6,CA9,CHRNA9,CXCL10,GABRP,SCN1A",7
"Organismal Injury and Abnormalities,Psychological Disorders","Generalized social anxiety disorder",0.000517,"CA6,CA9,SCN1A",3
"Hereditary Disorder,Nutritional Disease,Organismal Injury and Abnormalities,Psychological Disorders","Bulimia nervosa",0.000517,"CA6,CA9,SCN1A",3
"Drug Metabolism,Endocrine System Development and Function,Lipid Metabolism,Small Molecule Biochemistry","Glucuronidation of beta-estradiol",0.000529,"UGT1A9 (includes others),UGT2B28",2
"Cancer,Organismal Injury and Abnormalities","Tumorigenesis of cancer stem cells",0.000529,"GLDC,LIN28B",2
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Familial focal epilepsy",0.000534,"CA6,CA9,GAL,KCNQ2,SCN1A",5
"Psychological Disorders","Major affective disorder",0.000536,"CA6,CA9,CCKBR,CHGA,CHRNA9,CXCL10,DDC,FADS2,GABRP,GLDC,OPRK1,SCN1A,SLC1A6,STRA8",14
"Embryonic Development,Hair and Skin Development and Function,Organ Development,Organismal Development,Tissue Development","Formation of epidermis",0.00057,"CASP14,KRT34,KRT83,KRT85,SPRR1A",5
"Endocrine System Disorders,Gastrointestinal Disease,Metabolic Disease,Organismal Injury and Abnormalities","Adult-onset diabetes mellitus",0.000602,"CA6,CA9,FOXA2,SCN1A",4
"Psychological Disorders","Alcohol use disorder",0.000705,"CA6,CA9,CXCL10,GABBR2,GABRP,OPRK1,SCN1A",7
"Respiratory Disease","Sleep disordered breathing",0.000732,"CA6,CA9,DDC,GABRP,SCN1A,SLC12A1",6
"Nutritional Disease","Pediatric obesity",0.000733,"CA6,CA9,CARTPT,GABRP,SCN1A",5
"Nutritional Disease,Psychological Disorders","Eating Disorders",0.000767,"CA6,CA9,CARTPT,GABRP,OPRK1,SCN1A",6
"Neurological Disease","Injury of nervous system",0.000789,"CA6,CA9,CHGA,CHRNA9,GABBR2,GABRP,SCN1A",7
"Organismal Injury and Abnormalities,Renal and Urological Disease","Kidney stones",0.000789,"CA6,CA9,HAO1,OPRK1",4
"Auditory Disease,Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Cholesteatoma formation",0.000789,"CDH19,MMP1,PI3,S100A8",4
"Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Abnormality of skin morphology",0.000793,"CASP14,CCL7,CDH1,CDH19,DCD,FABP7,FADS2,GAL,KRT6C,MMP1,PI3,S100A2,S100A8",13
"Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Hyperkeratosis",0.000826,"CDH19,KRT6C,MMP1,PI3,S100A8",5
"Cardiovascular Disease,Organismal Injury and Abnormalities","Mild aortic stenosis",0.000983,"CA6,CA9,SLC12A1",3
"Cardiovascular Disease,Organismal Injury and Abnormalities","Mild aortic regurgitation",0.000983,"CA6,CA9,SLC12A1",3
"Cardiovascular Disease,Organismal Injury and Abnormalities","Moderate aortic stenosis",0.000983,"CA6,CA9,SLC12A1",3
"Cardiovascular Disease,Organismal Injury and Abnormalities","Moderate aortic regurgitation",0.000983,"CA6,CA9,SLC12A1",3
"Metabolic Disease,Organismal Injury and Abnormalities","Metabolic alkalosis",0.000983,"CA6,CA9,SLC12A1",3
"Metabolic Disease,Organismal Injury and Abnormalities","Diabetes insipidus",0.000983,"CA6,CA9,SLC12A1",3
"Endocrine System Disorders,Organismal Injury and Abnormalities,Renal and Urological Disease","Hypercalciuria",0.00119,"CA6,CA9,HAO1,SLC12A1",4
"Neurological Disease,Organismal Injury and Abnormalities","Localization-related epilepsy",0.00119,"CA6,CA9,GABRP,GAL,KCNQ2,SCN1A",6
"Protein Synthesis","Metabolism of cellular protein",0.00119,"AMTN,CP,FGA,H3C8,MMP1,MSLN,SFTA3,SFTPC",8
"Neurological Disease,Organismal Injury and Abnormalities","Migraine with typical aura",0.00129,"CA6,CA9,SCN1A",3
"Psychological Disorders","Cigarette habituation susceptibility syndrome",0.00131,"DDC,GABBR2",2
"Organismal Injury and Abnormalities","Breakthrough pain",0.00131,"OPRK1,SCN1A",2
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Benign rolandic epilepsy",0.00138,"CA6,CA9,KCNQ2,SCN1A",4
"Molecular Transport","Secretion of molecule",0.00139,"ANKRD1,CARTPT,CHGA,FGA,FGB,FOXA2,GAL,LACRT,SLC1A6",9
"Neurological Disease,Organismal Injury and Abnormalities","Encephalopathy with late-onset epilepsy",0.00143,"CA6,CA9,GABRP,KCNQ2,SCN1A",5
"Developmental Disorder,Neurological Disease,Psychological Disorders","Aphasia",0.00146,"CA6,CA9,DDC",3
"Endocrine System Development and Function,Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism","Metabolism of estrogen",0.00146,"UGT1A9 (includes others),UGT2B11,UGT2B4",3
"Cardiovascular Disease,Organismal Injury and Abnormalities,Renal and Urological Disease","Cardiorenal syndrome",0.00146,"CA6,CA9,SLC12A1",3
"Neurological Disease,Organismal Injury and Abnormalities","Primary tonic-clonic seizure",0.00146,"CA6,CA9,SCN1A",3
"Neurological Disease,Organismal Injury and Abnormalities","Chronic migraine",0.00146,"CA6,CA9,SCN1A",3
"Cancer,Gastrointestinal Disease,Hepatic System Disease,Organismal Injury and Abnormalities","Cholangiocarcinoma",0.0017,"AFAP1-AS1,CDH1,FGA,KRT20,UGT1A6,UGT1A9 (includes others)",6
"Cardiovascular Disease,Organismal Injury and Abnormalities","Cardiovascular disorder of cardiac valve",0.00171,"CA6,CA9,GABRP,SLC12A1",4
"Cardiovascular Disease,Organismal Injury and Abnormalities","Valvular regurgitation",0.00171,"CA6,CA9,GABRP,SLC12A1",4
"Psychological Disorders","Alcohol abuse",0.00171,"CA6,CA9,OPRK1,SCN1A",4
"Respiratory Disease","Respiratory distress syndrome",0.00177,"ACE2,CHRNA9,CXCL10,GABRP,NKX2-1,SCN1A",6
"Skeletal and Muscular Disorders","Abnormality of limb",0.00179,"COL9A3,KRT81,KRT83,KRT85,MMP1,OPRK1,SCN1A",7
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Familial hemiplegic migraine",0.00182,"OPRK1,SCN1A",2
"Cardiovascular Disease,Organismal Injury and Abnormalities","Hemorrhagic shock",0.00182,"CXCL10,OPRK1",2
"Gastrointestinal Disease,Organismal Injury and Abnormalities","Disorder of appendix",0.00183,"CHRNA9,KRT20,OPRK1,SCN1A",4
"Cancer,Organismal Injury and Abnormalities,Respiratory Disease","Non-small cell lung carcinoma",0.00186,"A2ML1,ACE2,ACTN2,AFAP1-AS1,CA9,CCKBR,CDH1,CYP24A1,CYP27C1,DIO1,DLK1,DLX6,DMRT1,DNER,EN1,FGB,GABRP,GLDC,HAO1,KCNQ2,KCNV1,KIF1A,KLHL1,KRT20,KRT38,KRT6C,LCT,LIN28B,LINC00261,LUZP4,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB4,MMP1,MUC21,NKX2-1,NR2E1,PCDH11X,PCDH8,POU4F1,PRAME,PXDNL,RAET1L,RCOR2,SCN1A,SH3GL3,SLC28A1,SLC39A12,SPANXB1 (includes others),UGT1A9 (includes others),UGT2B11,ZFP42,ZP4",54
"Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders","Obsessive-compulsive spectrum disorder",0.00192,"CA6,CA9,CARTPT,GABRP,SCN1A",5
"Cardiovascular Disease","Resistant hypertension",0.00207,"CA6,CA9,SLC12A1",3
"Cardiovascular Disease","Vasospasm",0.00207,"CA6,CA9,SCN1A",3
"Neurological Disease,Psychological Disorders","Major depression",0.00213,"CCKBR,CHGA,CHRNA9,CXCL10,DDC,GABRP,OPRK1,SCN1A,SLC1A6",9
"Organismal Injury and Abnormalities,Renal and Urological Disease","Acute kidney injury",0.00231,"CA6,CA9,GABRP,SCN1A,SLC12A1",5
"Psychological Disorders","Borderline personality disorder",0.00237,"CA6,CA9,GABRP,SCN1A",4
"Respiratory Disease","Sleep apnea syndrome",0.00253,"CA6,CA9,DDC,GABRP,SLC12A1",5
"Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Pruritus",0.00254,"CCL7,CHRNA9,CXCL10,IL36A,OPRK1,S100A2",6
"Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Keratosis",0.00263,"CDH1,CDH19,KRT6C,MMP1,PI3,S100A8",6
"Neurological Disease","Sedation",0.00268,"CHRNA9,GABRP,OPRK1,SCN1A",4
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease","Female genital tract serous carcinoma",0.00269,"CDH1,CP,CRABP1,FOXA2,GAL,INA,KRT20,KRT34,KRT81,MSLN,PI3,S100A2,VGLL1",13
"Cancer,Organismal Injury and Abnormalities","Pelvic serous carcinoma",0.00269,"CDH1,CP,CRABP1,FOXA2,GAL,INA,KRT20,KRT34,KRT81,MSLN,PI3,S100A2,VGLL1",13
"Cardiovascular Disease,Organismal Injury and Abnormalities,Respiratory Disease","Pulmonary Hypertension",0.00272,"CA6,CA9,CHRNA9,CXCL10,GABRP,SCN1A",6
"Carbohydrate Metabolism,Lipid Metabolism,Small Molecule Biochemistry","Binding of lipopolysaccharide",0.00308,"BPI,LBP",2
"Cardiovascular Disease","Prehypertension",0.0031,"CA6,CA9,SLC12A1",3
"Developmental Disorder,Neurological Disease,Organismal Injury and Abnormalities","Lennox-Gastaut syndrome",0.00319,"CA6,CA9,GABRP,SCN1A",4
"Organismal Injury and Abnormalities,Psychological Disorders","Generalized anxiety disorder",0.00337,"CA6,CA9,GABRP,SCN1A",4
"Gastrointestinal Disease,Inflammatory Disease,Inflammatory Response,Organismal Injury and Abnormalities","Appendicitis",0.0034,"CHRNA9,OPRK1,SCN1A",3
"Cardiovascular Disease,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Brugada syndrome type 1",0.0034,"ANKRD1,HCN4,KCNE5",3
"Neurological Disease,Organismal Injury and Abnormalities","Migraine with aura",0.00357,"CA6,CA9,OPRK1,SCN1A",4
"Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders","Brain damage",0.00365,"CA6,CA9,CHRNA9,GABBR2,GABRP,SCN1A",6
"Ophthalmic Disease,Organismal Injury and Abnormalities","Angle-closure glaucoma",0.00371,"CA6,CA9,SCN1A",3
"Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Anterior cruciate ligament injury",0.00371,"GABRP,OPRK1,SCN1A",3
"Cardiovascular Disease,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Familial left ventricular noncompaction",0.00371,"ACTN2,ANKRD1,HCN4",3
"Skeletal and Muscular Disorders","Hallux valgus",0.00382,"OPRK1,SCN1A",2
"Cardiovascular Disease,Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Stasis ulcer",0.00382,"FGA,FGB",2
"Neurological Disease,Organismal Injury and Abnormalities","Tonic-clonic seizure",0.00389,"CA6,CA9,GABBR2,GABRP,KCNQ2,SCN1A",6
"Molecular Transport","Transport of bicarbonate",0.00404,"CA6,CA9,SLC26A9",3
"Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities","Small-cell carcinoma",0.00424,"C18orf63,C1orf94,CALCB,CCKBR,CDH19,CHGA,CHRDL2,CT83,DDC,DLX6,DNER,FBN3,FETUB,FGA,FZD9,GLDC,HRCT1,IL36A,KLHL1,KRT20,LACRT,LCT,LUZP4,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB4,NETO1,NKX2-1,NR2E1,OPRK1,PCDH11X,PGBD5,PXDNL,RGR,S100A8,SCN1A,SH3GL3,SLC12A1,SLC26A9,SLIT1,SMR3A,STRA8,SULT1C3,TAFA4,TBXT,TMPRSS4,UGT1A6,UGT1A9 (includes others),UGT2B10,ZP4",52
"Gastrointestinal Disease","Vomiting",0.0043,"CA6,CA9,GABRP,OPRK1,SCN1A",5
"Hematological Disease,Metabolic Disease,Organismal Injury and Abnormalities","Hypokalemia",0.00439,"CA6,CA9,SLC12A1",3
"Auditory Disease","Tinnitus",0.00439,"CA6,CA9,SCN1A",3
"Neurological Disease,Organismal Injury and Abnormalities","Generalized epilepsy",0.00481,"CA6,CA9,GABBR2,GABRP,KCNQ2,SCN1A",6
"Dermatological Diseases and Conditions,Inflammatory Disease,Organismal Injury and Abnormalities","Acne",0.00481,"CA6,CA9,MMP1,PI3,UGT1A9 (includes others)",5
"Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders","Traumatic brain injury",0.00481,"CA6,CA9,CHRNA9,GABRP,SCN1A",5
"Organismal Injury and Abnormalities,Respiratory Disease","Obstructive sleep apnea",0.00487,"CA6,CA9,DDC,GABRP",4
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease","Hyperplasia of genital organ",0.00487,"CDH1,FOXA2,GABRP,MMP1",4
"Respiratory Disease","Lower respiratory tract disorder",0.00507,"CA6,CA9,CHRNA9,CYP2A6 (includes others),DLK1,GABRP,LBP,MMP1,NKX2-1,OPRK1",10
"Neurological Disease,Psychological Disorders","Attention deficit hyperactivity disorder",0.00512,"CARTPT,FADS2,GABRP,OPRK1",4
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Autosomal dominant early infantile epileptic encephalopathy",0.00514,"GABBR2,KCNQ2,SCN1A",3
"Cancer,Organismal Injury and Abnormalities,Respiratory Disease","Primary non-small cell lung carcinoma",0.00514,"GLDC,LIN28B,NKX2-1",3
"Immunological Disease","Delayed hypersensitive reaction",0.00514,"KRT6C,PI3,S100A2",3
"Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Plaque psoriasis",0.00524,"CXCL10,KRT6C,PI3,S100A8,SPRR1A,SPRR2D",6
"Gastrointestinal Disease,Organismal Injury and Abnormalities","Esophageal lesion",0.00531,"CA9,CDH1,CRISP3,DLX6,FADS2,KRT20,LACRT,LBP,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,PADI3,PROKR2,PXDNL,S100A8,SCN1A,SLC39A12,STRA8,UBD",19
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function","Aggregation of blood cells",0.00536,"CDH1,CXCL10,FGA,FGB,S100A8",5
"Psychological Disorders","Opioid-related disorder",0.00537,"CA6,CA9,GABRP,OPRK1",4
"Cancer,Organismal Injury and Abnormalities","Blue round small cell tumor",0.0054,"A2ML1,C18orf63,C1orf94,CALCB,CCKBR,CDH19,CHGA,CHRDL2,CT83,DDC,DLX6,DNER,FBN3,FETUB,FGA,FZD9,GLDC,HRCT1,IL36A,KCNE5,KLHL1,KRT20,LACRT,LCT,LIN28B,LMO1,LUZP4,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB4,NETO1,NKX2-1,NR2E1,OPRK1,PCDH11X,PGBD5,PXDNL,RGR,S100A8,SCN1A,SH3GL3,SLC12A1,SLC26A9,SLIT1,SMR3A,STRA8,SULT1C3,TAFA4,TBXT,TMPRSS4,UGT1A6,UGT1A9 (includes others),UGT2B10,ZP4",56
"Organismal Injury and Abnormalities","Extraintestinal functional disorder",0.00552,"CA6,CA9,CARTPT,CHRNA9,CP,GABRP,LBX1,OPRK1,SCN1A,SLC1A6",10
"Organismal Injury and Abnormalities","Acute postoperative pain",0.00554,"OPRK1,SCN1A",2
"Cardiovascular Disease,Neurological Disease,Organismal Injury and Abnormalities","Cerebral vasospasm",0.00554,"CA6,CA9",2
"Developmental Disorder,Organismal Injury and Abnormalities","Drug induced edema",0.00554,"CA6,CA9",2
"Gastrointestinal Disease,Organismal Injury and Abnormalities","Periodontal disease",0.00555,"CRNN,MMP1,PRSS33,SCN1A,SPRR1A,SPRR2D",6
"Developmental Disorder,Neurological Disease,Organismal Injury and Abnormalities","Developmental epilepsy",0.00571,"CA6,CA9,GABBR2,GABRP,KCNQ2,SCN1A",6
"Antimicrobial Response,Inflammatory Response","Antimicrobial response",0.00572,"BPI,CHGA,DCD,LACRT,OPRK1,PI3,PRSS3,S100A8",8
"Gastrointestinal Disease,Organismal Injury and Abnormalities","Chronic periodontal disease",0.00575,"CRNN,MMP1,PRSS33,SPRR1A,SPRR2D",5
"Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism","Metabolism of terpenoid",0.00596,"CYP24A1,CYP27C1,CYP2A6 (includes others),RLBP1,UGT1A9 (includes others),UGT2B11,UGT2B28,UGT2B4",8
"Organismal Injury and Abnormalities,Psychological Disorders","Anxiety Disorders",0.00621,"CA6,CA9,CARTPT,GABRP,SCN1A,SLC1A6",6
"Cancer,Organismal Injury and Abnormalities","Nonhematologic malignant neoplasm",0.00634,"A2ML1,AARD,ACE2,ACTL8,ACTN2,AFAP1-AS1,AMTN,ANKRD1,ART3,BARHL2,BPI,C11orf86,C18orf63,C1orf94,CA6,CA9,CALCB,CARTPT,CASP14,CCKBR,CCL7,CDH1,CDH19,CDK5R2,CELF4,CHGA,CHODL,CHRDL2,CHRNA9,CLDN6,COL9A3,CP,CPB1,CRABP1,CRISP3,CRNN,CT83,CXCL10,CYP24A1,CYP27C1,CYP2A6 (includes others),CYP2F1,DCD,DDC,DHRS2,DIO1,DLK1,DLX6,DMRT1,DNER,ELF5,EN1,FABP7,FADS2,FBN3,FETUB,FGA,FGB,FOXA2,FZD9,GABBR2,GABRP,GAL,GGTLC2,GLDC,GNAT3,GNGT1,GSTA2,HAO1,HCN4,HORMAD1,HRCT1,IL36A,INA,KCNE5,KCNQ2,KCNV1,KIF1A,KLHL1,KLHL34,KRT20,KRT34,KRT38,KRT6C,KRT75,KRT81,KRT83,KRT85,LACRT,LBP,LBX1,LCT,LEMD1,LIN28B,LINC00261,LMO1,LUZP4,LY6D,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB1,MAGEB4,MMP1,MSLN,MUC21,NETO1,NGB,NKX1-2,NKX2-1,NR2E1,OPRK1,PADI3,PCDH11X,PCDH8,PCSK1N,PGBD5,PGPEP1L,PI3,PNMA6E,POU4F1,PPDPFL,PPP1R14C,PRAME,PRDM13,PRKAG3,PROKR2,PRR27,PRSS3,PRSS33,PSAPL1,PXDNL,RAB3B,RAET1L,RCOR2,RGR,RLBP1,ROPN1,S100A2,S100A8,SCHLAP1,SCN1A,SFTA3,SFTPC,SH3GL3,SLC12A1,SLC15A1,SLC1A6,SLC26A9,SLC28A1,SLC39A12,SLC6A17,SLIT1,SMC1B,SMOC1,SMR3A,SOST,SOX11,SPANXB1 (includes others),SPDYC,SPRR1A,SPRR2D,STRA8,SULT1C3,SVOP,TAFA4,TBXT,TCAM1P,TCERG1L,TLX3,TMPRSS4,TMSB15A,TRIM15,TRIM43/TRIM43B,UBD,UGT1A6,UGT1A9 (includes others),UGT2A3,UGT2B10,UGT2B11,UGT2B28,UGT2B4,VGLL1,WNT6,ZFP42,ZNF280A,ZP4",188
"Neurological Disease,Psychological Disorders","Bipolar disorder",0.00635,"CA6,CA9,FADS2,GABRP,GLDC,OPRK1,SCN1A,SLC1A6,STRA8",9
"Cardiovascular Disease,Organismal Injury and Abnormalities","Left ventricular dysfunction",0.00637,"ACE2,ACTN2,ANKRD1,HCN4,MMP1",5
"Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities","Prader-Willi syndrome",0.0064,"CA6,CA9,SCN1A",3
"Neurological Disease,Organismal Injury and Abnormalities","Partial seizure",0.00646,"CA6,CA9,GABRP,SCN1A",4
"Developmental Disorder,Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders","Landau Kleffner syndrome",0.00651,"CA6,CA9",2
"Cellular Development,Nervous System Development and Function,Tissue Development","Differentiation of dopaminergic neurons",0.00651,"EN1,FOXA2",2
"Cancer,Cellular Development,Cellular Growth and Proliferation,Organismal Injury and Abnormalities,Tumor Morphology","Proliferation of cancer stem cells",0.00651,"GLDC,LIN28B",2
"Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Osteoporosis",0.00676,"CA6,CA9,SLC12A1,SOST",4
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities","Esophageal carcinoma",0.00681,"CA9,CDH1,DLX6,FADS2,KRT20,LACRT,LBP,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,PADI3,PROKR2,PXDNL,S100A8,SCN1A,SLC39A12,STRA8",17
"Organismal Injury and Abnormalities","Bleeding",0.00725,"CA6,CA9,CHRNA9,FGA,FGB,GABRP,SCN1A",7
"Inflammatory Disease,Ophthalmic Disease,Organismal Injury and Abnormalities","Anterior uveitis",0.00733,"CA6,CA9,GABRP",3
"Neurological Disease","Tremor",0.00738,"CA6,CA9,GABRP,SCN1A",4
"Organismal Injury and Abnormalities","Acute pain",0.00738,"GABBR2,GABRP,OPRK1,SCN1A",4
"Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Psoriasis",0.00741,"CDH1,CXCL10,DCD,FABP7,FADS2,GAL,KRT6C,MMP1,PI3,PRSS3,S100A2,S100A8,SLC1A6,SPRR1A,SPRR2D",15
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities","Gastro-esophageal carcinoma",0.00743,"A2ML1,AMTN,ART3,BPI,CA9,CCKBR,CDH1,CELF4,CHGA,CHRDL2,COL9A3,CRNN,CYP2A6 (includes others),CYP2F1,DLK1,DLX6,DMRT1,DNER,EN1,FABP7,FADS2,FBN3,FETUB,FGA,FOXA2,GABRP,GNGT1,INA,KCNQ2,KCNV1,KIF1A,KLHL1,KLHL34,KRT20,LACRT,LBP,LBX1,LCT,LINC00261,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,NETO1,NGB,NKX1-2,OPRK1,PADI3,PCDH11X,PI3,POU4F1,PROKR2,PRR27,PRSS3,PXDNL,RCOR2,S100A2,S100A8,SCN1A,SLC1A6,SLC26A9,SLC39A12,SOX11,STRA8,TCERG1L,TRIM15,UGT1A6,UGT1A9 (includes others),UGT2B11,UGT2B4,WNT6,ZFP42,ZP4",73
"Ophthalmic Disease,Organismal Injury and Abnormalities","Secondary glaucoma",0.00754,"CA6,CA9",2
"Organismal Injury and Abnormalities,Respiratory Disease","High-altitude pulmonary edema",0.00754,"CA6,CA9",2
"Hematological Disease","Acquired hemophilia",0.00754,"FGA,FGB",2
"Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Spondylolisthesis",0.00754,"OPRK1,SCN1A",2
"Developmental Disorder,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities","Congenital disorder of glycosylation type 1a",0.00754,"CA6,CA9",2
"Cell-To-Cell Signaling and Interaction,Molecular Transport,Small Molecule Biochemistry","Secretion of catecholamine",0.00754,"CARTPT,CHGA",2
"Hematological Disease,Hereditary Disorder,Organismal Injury and Abnormalities","Hemophilia A",0.00754,"FGA,FGB",2
"Neurological Disease,Organismal Injury and Abnormalities","Subarachnoid hemorrhage",0.0077,"CA6,CA9,CHRNA9,GABRP",4
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities","Gastroesophageal cancer",0.00782,"A2ML1,AMTN,ART3,BPI,CA9,CCKBR,CDH1,CELF4,CHGA,CHRDL2,COL9A3,CRNN,CYP2A6 (includes others),CYP2F1,DDC,DLK1,DLX6,DMRT1,DNER,EN1,FABP7,FADS2,FBN3,FETUB,FGA,FOXA2,GABRP,GNGT1,INA,KCNQ2,KCNV1,KIF1A,KLHL1,KLHL34,KRT20,LACRT,LBP,LBX1,LCT,LINC00261,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,NETO1,NGB,NKX1-2,OPRK1,PADI3,PCDH11X,PI3,POU4F1,PROKR2,PRR27,PRSS3,PXDNL,RCOR2,S100A2,S100A8,SCN1A,SLC1A6,SLC26A9,SLC39A12,SOX11,STRA8,TCERG1L,TMPRSS4,TRIM15,UGT1A6,UGT1A9 (includes others),UGT2B11,UGT2B4,WNT6,ZFP42,ZP4",75
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Fragile X syndrome",0.00783,"GABBR2,SCN1A,SLC1A6",3
"Organismal Injury and Abnormalities","Shoulder pain",0.00783,"CHRNA9,OPRK1,SCN1A",3
"Cardiovascular Disease","Primary hypertension",0.00801,"ACE2,CA6,CA9,DDC,SLC12A1",5
"Organismal Injury and Abnormalities","Disorder of pigmentation",0.00826,"CP,FABP7,FADS2,GAL,UGT1A6",5
"Neurological Disease","Essential tremor",0.00834,"CA6,CA9,SCN1A",3
"Inflammatory Disease,Organismal Injury and Abnormalities,Respiratory Disease","Acute respiratory distress syndrome",0.00853,"ACE2,CHRNA9,CXCL10,GABRP,SCN1A",5
"Hematological Disease,Metabolic Disease,Organismal Injury and Abnormalities","Diuretic-induced hypokalemia",0.00865,"CA6,CA9",2
"Cellular Development,Cellular Growth and Proliferation","Proliferation of embryonic cancer cell lines",0.00865,"LINC00261,TBXT",2
"Neurological Disease,Organismal Injury and Abnormalities","Generalized convulsive epilepsy",0.00879,"CA6,CA9,GABBR2,KCNQ2,SCN1A",5
"Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders","Withdrawal syndrome",0.00888,"CHRNA9,GABBR2,GABRP",3
"Gastrointestinal Disease,Organismal Injury and Abnormalities","Ileus",0.00888,"GABRP,OPRK1,SCN1A",3
"Endocrine System Disorders,Metabolic Disease,Organismal Injury and Abnormalities","Insulin resistance",0.009,"CA6,CA9,FOXA2,LBP,OPRK1,S100A8,SCN1A",7
"Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities","Neuroendocrine tumor",0.00905,"C18orf63,C1orf94,CALCB,CARTPT,CCKBR,CDH19,CHGA,CHRDL2,CT83,DDC,DLX6,DNER,FBN3,FETUB,FGA,FZD9,GAL,GLDC,GNGT1,HRCT1,IL36A,KLHL1,KRT20,LACRT,LCT,LUZP4,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB4,NETO1,NKX2-1,NR2E1,OPRK1,PCDH11X,PGBD5,PXDNL,RGR,S100A8,SCN1A,SH3GL3,SLC12A1,SLC26A9,SLIT1,SMR3A,STRA8,SULT1C3,TAFA4,TBXT,TLX3,TMPRSS4,UGT1A6,UGT1A9 (includes others),UGT2B10,ZP4",56
"Organismal Injury and Abnormalities,Psychological Disorders","Social anxiety disorder",0.00908,"CA6,CA9,SCN1A,SLC1A6",4
"Nutritional Disease","Weight gain",0.00908,"CA6,CA9,GABRP,SCN1A",4
"Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities","Endocrine gland tumor",0.00942,"A2ML1,AARD,ACE2,ACTL8,ACTN2,AFAP1-AS1,AMTN,ANKRD1,BARHL2,BPI,C11orf86,C18orf63,C1orf94,CA6,CA9,CALCB,CARTPT,CASP14,CCKBR,CDH1,CDH19,CDK5R2,CELF4,CHGA,CHODL,CHRDL2,CHRNA9,CLDN6,COL9A3,CP,CPB1,CRABP1,CT83,CYP24A1,CYP27C1,CYP2A6 (includes others),CYP2F1,DDC,DHRS2,DIO1,DLX6,DMRT1,DNER,ELF5,EN1,FADS2,FBN3,FETUB,FGA,FGB,FOXA2,FZD9,GABBR2,GABRP,GAL,GGTLC2,GLDC,GNAT3,GNGT1,HCN4,HORMAD1,HRCT1,IL36A,INA,KCNE5,KCNQ2,KCNV1,KIF1A,KLHL1,KLHL34,KRT20,KRT34,KRT38,KRT6C,KRT75,KRT81,KRT83,KRT85,LACRT,LBP,LCT,LMO1,LUZP4,LY6D,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB1,MAGEB4,MMP1,MSLN,NETO1,NKX1-2,NKX2-1,NR2E1,OPRK1,PADI3,PCDH11X,PCDH8,PCSK1N,PGBD5,POU4F1,PPDPFL,PPP1R14C,PRAME,PRDM13,PRKAG3,PROKR2,PRSS3,PRSS33,PXDNL,RAET1L,RCOR2,RGR,RLBP1,S100A8,SCN1A,SH3GL3,SLC12A1,SLC15A1,SLC1A6,SLC26A9,SLC28A1,SLC39A12,SLC6A17,SLIT1,SMC1B,SMOC1,SMR3A,SOST,SOX11,SPANXB1 (includes others),SPDYC,STRA8,SULT1C3,SVOP,TAFA4,TBXT,TCERG1L,TLX3,TMPRSS4,TRIM15,TRIM43/TRIM43B,UGT1A6,UGT1A9 (includes others),UGT2A3,UGT2B10,UGT2B11,UGT2B28,UGT2B4,VGLL1,WNT6,ZP4",154
"Respiratory Disease","Respiratory insufficiency",0.00943,"CA6,CA9,CHRNA9",3
"Cardiovascular Disease,Hereditary Disorder,Organismal Injury and Abnormalities","Inherited arrhythmia syndrome",0.00945,"ACTN2,ANKRD1,HCN4,KCNE5",4
"Cancer,Cellular Movement,Organismal Injury and Abnormalities","Invasion of mammary epithelial cells",0.00948,"MMP1",1
"Developmental Disorder,Endocrine System Disorders,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities,Reproductive System Disease","Hypogonadotropic hypogonadism 3 without anosmia",0.00948,"PROKR2",1
"Cancer,Endocrine System Disorders,Gastrointestinal Disease,Organismal Injury and Abnormalities","Non-functional pancreatic neuroendocrine tumor",0.00948,"CHGA",1
"Organismal Injury and Abnormalities,Renal and Urological Disease","Urinary bladder voiding dysfunction",0.00948,"SCN1A",1
"Cell Death and Survival","Cell viability of bronchial epithelial cells",0.00948,"UBD",1
"Developmental Disorder,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities","Uridine-cytidineuria",0.00948,"SLC28A1",1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Susceptibility to familial febrile seizures type 3A",0.00948,"SCN1A",1
"Cardiovascular Disease,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Sick sinus syndrome 2 with cardiac noncompaction",0.00948,"HCN4",1
"Developmental Disorder,Endocrine System Disorders,Hereditary Disorder,Metabolic Disease,Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders,Respiratory Disease","Congenital hypothyroidism with choreoathetosis and neonatal resporatory distress",0.00948,"NKX2-1",1
"Hereditary Disorder,Organismal Functions,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Autosomal dominant adult-onset distal myopathy type 6",0.00948,"ACTN2",1
"Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Congenital myopathy with structured cores and Z-line abnormalities",0.00948,"ACTN2",1
"Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization","Cell-cell contact of squamous carcinoma cells",0.00948,"CDH1",1
"Ophthalmic Disease,Organismal Injury and Abnormalities","Retinitis pigmentosa type 44",0.00948,"RGR",1
"Cellular Movement","Intravasation of squamous cell carcinoma cell lines",0.00948,"MMP1",1
"Amino Acid Metabolism,Molecular Transport,Small Molecule Biochemistry","Quantity of L-leucine",0.00948,"CA9",1
"Dental Disease,Developmental Disorder,Gastrointestinal Disease,Hereditary Disorder,Organismal Injury and Abnormalities","Amelogenesis imperfecta type IIIB",0.00948,"AMTN",1
"Cellular Movement","Transepithelial migration of squamous cell carcinoma cell lines",0.00948,"CDH1",1
"Developmental Disorder,Endocrine System Disorders,Hematological Disease,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities,Renal and Urological Disease","Bartter syndrome type 1",0.00948,"SLC12A1",1
"Cancer,Organismal Injury and Abnormalities","Transformation of RPE cells",0.00948,"PGBD5",1
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Early infantile epileptic encephalopathy type 7",0.00948,"KCNQ2",1
"Cellular Movement","Transepithelial migration of keratinocyte cancer cell lines",0.00948,"CDH1",1
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities","TNM stage I gastric cancer",0.00948,"TMPRSS4",1
"Cell Death and Survival,Reproductive System Development and Function","Survival of mammary epithelial cells",0.00948,"EN1",1
"Lipid Metabolism,Small Molecule Biochemistry","Binding of lipoteichoic acid",0.00948,"LBP",1
"Embryonic Development,Nervous System Development and Function,Organ Development,Organismal Development,Tissue Development","Development of globus pallidus",0.00948,"NKX2-1",1
"Connective Tissue Disorders,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Autosomal dominant craniodiaphyseal dysplasia",0.00948,"SOST",1
"Cancer,Connective Tissue Disorders,Organismal Injury and Abnormalities,Respiratory Disease","Neoplastic cell transformation of pulmonary fibroblasts",0.00948,"GLDC",1
"Drug Metabolism","Storage of levodopa",0.00948,"CHGA",1
"Molecular Transport","Secretion of urea",0.00948,"FOXA2",1
"Cell-To-Cell Signaling and Interaction","Reactivity of natural killer cells",0.00948,"CDH1",1
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Early infantile epileptic encephalopathy type 59",0.00948,"GABBR2",1
"Developmental Disorder,Endocrine System Disorders,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities,Reproductive System Disease,Respiratory Disease","Kallmann syndrome type 3",0.00948,"PROKR2",1
"Cell Cycle","Arrest in Gap 0-Gap 1 phase of cholangiocarcinoma cell lines",0.00948,"AFAP1-AS1",1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Familial temporal lobe epilepsy type 8",0.00948,"GAL",1
"Developmental Disorder,Hereditary Disorder,Ophthalmic Disease,Organismal Injury and Abnormalities","Newfoundland rod-cone dystrophy",0.00948,"RLBP1",1
"Cancer,Gastrointestinal Disease,Hereditary Disorder,Organismal Injury and Abnormalities","Hereditary diffuse gastric adenocarcinoma",0.00948,"CDH1",1
"Cancer,Gastrointestinal Disease,Hereditary Disorder,Organismal Injury and Abnormalities","Autosomal dominant hereditary diffuse gastric cancer",0.00948,"CDH1",1
"Cell Morphology,Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization","Extension of focal adhesions",0.00948,"CDH1",1
"Amino Acid Metabolism,Energy Production,Post-Translational Modification,Small Molecule Biochemistry","Auto-oxidation of cystine",0.00948,"CP",1
"Connective Tissue Disorders,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Sclerosteosis type 1",0.00948,"SOST",1
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease","Well-differentiated malignant neoplasm of prostate",0.00948,"FABP7",1
"Cell Cycle","Arrest in S/G2 phase transition of breast cancer cell lines",0.00948,"FABP7",1
"Metabolic Disease,Organismal Injury and Abnormalities,Psychological Disorders","Protection against nicotine dependence",0.00948,"CYP2A6 (includes others)",1
"Cancer","Establishment of lung cancer cell lines",0.00948,"FZD9",1
"Developmental Disorder,Hereditary Disorder,Ophthalmic Disease,Organismal Injury and Abnormalities","Bothnia retinal dystrophy",0.00948,"RLBP1",1
"Cell Cycle","Exit from mitosis of lung cancer cell lines",0.00948,"CYP24A1",1
"Cell-To-Cell Signaling and Interaction","Adhesion of neural stem cells",0.00948,"CDH1",1
"Cancer,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Susceptibility to neuroblastoma type 7",0.00948,"LMO1",1
"Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities","Deficiency of aromatic-l-amino-acid decarboxylase",0.00948,"DDC",1
"Cell Cycle","Entry into S phase of skin cancer cell lines",0.00948,"CDH1",1
"Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities","Deficiency of ferroxidase",0.00948,"CP",1
"Cell Cycle","Tetraploidy of sarcoma cell lines",0.00948,"CDH1",1
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Myokymia with neonatal epilepsy",0.00948,"KCNQ2",1
"Drug Metabolism","Hydroxylation of coumarin",0.00948,"CYP2A6 (includes others)",1
"Cancer,Organismal Injury and Abnormalities,Respiratory Disease","Non-mucinous lung adenocarcinoma",0.00948,"NKX2-1",1
"DNA Replication, Recombination, and Repair,Nucleic Acid Metabolism,Small Molecule Biochemistry","Metabolism of deoxyuridine",0.00948,"GLDC",1
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Limb-brain type ENDOVE syndrome",0.00948,"EN1",1
"Cardiovascular Disease,Organismal Injury and Abnormalities,Reproductive System Disease","Postpartum preeclampsia",0.00948,"SLC12A1",1
"Dermatological Diseases and Conditions,Hereditary Disorder,Organismal Injury and Abnormalities","Susceptibility to pseudofolliculitis barbae",0.00948,"KRT75",1
"Organismal Development,Skeletal and Muscular System Development and Function","Formation of wing",0.00948,"VGLL1",1
"Hematological Disease,Metabolic Disease,Nutritional Disease,Organismal Injury and Abnormalities","Systemic hemosiderosis due to aceruloplasminemia",0.00948,"CP",1
"Cardiovascular System Development and Function,Cell-To-Cell Signaling and Interaction","Activation of HCAEC cells",0.00948,"LBP",1
"Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities,Reproductive System Disease","Primary small cell cervical cancer",0.00948,"NKX2-1",1
"Cell Cycle","Tetraploidy of bone cancer cell lines",0.00948,"CDH1",1
"Cell Death and Survival,Organismal Injury and Abnormalities","Apoptosis of squamous epithelial cells",0.00948,"CDH1",1
"Cell Cycle","Arrest in G0 phase of breast cell lines",0.00948,"PI3",1
"Cellular Function and Maintenance,Reproductive System Development and Function","Organization of gonadal cell lines",0.00948,"CDH1",1
"Amino Acid Metabolism,Energy Production,Post-Translational Modification,Small Molecule Biochemistry","Auto-oxidation of L-cysteine",0.00948,"CP",1
"Cardiovascular Disease,Hereditary Disorder,Organismal Injury and Abnormalities","Familial sinus bradycardia",0.00948,"HCN4",1
"Connective Tissue Disorders,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Sacral agenesis with vertebral anomalies",0.00948,"TBXT",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Extranodal mantle cell lymphoma",0.00948,"SOX11",1
"Developmental Disorder,Hereditary Disorder,Ophthalmic Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Microphthalmia with limb anomalies",0.00948,"SMOC1",1
"Drug Metabolism,Molecular Transport","Uptake of cephalexin",0.00948,"SLC15A1",1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Hereditary sensory neuropathy type IIC",0.00948,"KIF1A",1
"Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities","Erythrokeratodermia variabilis et progressiva 5",0.00948,"KRT83",1
"Developmental Disorder,Endocrine System Disorders,Hereditary Disorder,Organismal Injury and Abnormalities,Reproductive System Disease","46, XY sex reversal type 4",0.00948,"DMRT1",1
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders","Neurodevelopmental disorder with poor language and loss of hand skills",0.00948,"GABBR2",1
"Connective Tissue Disorders,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Multiple epiphyseal dysplasia with myopathy type 3",0.00948,"COL9A3",1
"Cardiovascular Disease,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Familial hypertrophic cardiomyopathy type 23",0.00948,"ACTN2",1
"Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities","Hereditary aceruloplasminemia",0.00948,"CP",1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Autosomal recessive spastic paraplegia type 30",0.00948,"KIF1A",1
"Endocrine System Disorders,Hematological Disease,Hereditary Disorder,Organismal Injury and Abnormalities","Infantile hypercalcemia type 1",0.00948,"CYP24A1",1
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease","Development of lobular breast adenocarcinoma",0.00948,"CDH1",1
"Cell Cycle","Exit from G1 phase of breast cancer cell lines",0.00948,"ELF5",1
"Cellular Assembly and Organization","Decapping of actin filaments",0.00948,"ACTN2",1
"Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Severe osteoporosis",0.00948,"SOST",1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Familial hemiplegic migraine type 3",0.00948,"SCN1A",1
"Cell Death and Survival","Killing of B lymphoblastoid cell lines",0.00948,"RAET1L",1
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Autosomal dominant mental retardation type 27",0.00948,"SOX11",1
"Cardiovascular Disease,Developmental Disorder,Organismal Injury and Abnormalities,Respiratory Disease","Total anomalous pulmonary venous return",0.00948,"ANKRD1",1
"Embryonic Development,Tissue Development","Adhesion of embryoblast",0.00948,"CDH1",1
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities","TNM stage II gastric cancer",0.00948,"TMPRSS4",1
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Benign familial neonatal seizures 1 and/or myokymia",0.00948,"KCNQ2",1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Generalized epilepsy with febrile seizures plus type 2",0.00948,"SCN1A",1
"Dermatological Diseases and Conditions,Infectious Diseases,Organismal Injury and Abnormalities","Scabies",0.00948,"SCN1A",1
"Developmental Disorder,Gastrointestinal Disease,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities","Congenital lactase deficiency",0.00948,"LCT",1
"Connective Tissue Disorders,Developmental Disorder,Gastrointestinal Disease,Hereditary Disorder,Ophthalmic Disease,Organismal Development,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Blepharocheilodontic syndrome type 1",0.00948,"CDH1",1
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Autosomal dominant mental retardation type 9",0.00948,"KIF1A",1
"Developmental Disorder,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities,Respiratory Disease","Surfactant metabolism dysfunction due to protein C deficiency",0.00948,"SFTPC",1
"Hereditary Disorder,Organismal Injury and Abnormalities","FGA-related disorder",0.00948,"FGA",1
"Neurological Disease,Organismal Injury and Abnormalities","Drug resistant multifocal epilepsy",0.00948,"SCN1A",1
"Amino Acid Metabolism,Molecular Transport,Small Molecule Biochemistry","Quantity of L-tryptophan",0.00948,"CA9",1
"Cancer,Connective Tissue Disorders,Developmental Disorder,Gastrointestinal Disease,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Hereditary diffuse gastric cancer and cleft lip",0.00948,"CDH1",1
"Cell Death and Survival","Killing of Bacillus anthracis",0.00948,"CXCL10",1
"Cell Cycle","Exit from mitosis of adenocarcinoma cell lines",0.00948,"CYP24A1",1
"Cardiovascular Disease,Organismal Injury and Abnormalities","Trauma-hemorrhagic shock",0.00948,"CXCL10",1
"Amino Acid Metabolism,Molecular Transport,Small Molecule Biochemistry","Quantity of L-methionine",0.00948,"CA9",1
"Cardiovascular Disease,Cardiovascular System Development and Function,Hereditary Disorder,Organ Morphology,Organismal Development,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Dilated cardiomyopathy type 1AA",0.00948,"ACTN2",1
"Cardiovascular Disease,Cardiovascular System Development and Function,Hereditary Disorder,Organ Morphology,Organismal Development,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","ANKRD1-related dilated cardiomyopathy",0.00948,"ANKRD1",1
"Cellular Assembly and Organization","Formation of filamentous network",0.00948,"INA",1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Autosomal dominant benign hereditary chorea",0.00948,"NKX2-1",1
"Cardiovascular Disease,Hereditary Disorder,Organismal Injury and Abnormalities","Sick sinus syndrome type 2 with cardiac noncompaction and ascending aorta dilation",0.00948,"HCN4",1
"Carbohydrate Metabolism,Small Molecule Biochemistry","Dissociation of lipopolysaccharide",0.00948,"LBP",1
"Cell Death and Survival","Cell viability of embryonic cancer cell lines",0.00948,"TBXT",1
"Small Molecule Biochemistry","Catabolism of glycolic acid",0.00948,"HAO1",1
"Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities","Autosomal recessive congenital ichthyosis type 12",0.00948,"CASP14",1
"Lipid Metabolism,Small Molecule Biochemistry","Mobilization of all-trans-retinyl esters",0.00948,"RGR",1
"Drug Metabolism","Catabolism of coumarin",0.00948,"CYP2A6 (includes others)",1
"Gastrointestinal Disease,Hepatic System Disease,Organismal Injury and Abnormalities","Hepatic insufficiency",0.00948,"CHGA",1
"Cellular Development,Cellular Growth and Proliferation","Delay in growth of breast cancer cell lines",0.00948,"CA9",1
"Cancer,Organismal Injury and Abnormalities","Metastasis of squamous cell carcinoma cell lines",0.00948,"MMP1",1
"Small Molecule Biochemistry","Production of putrescine",0.00948,"CA9",1
"Cellular Assembly and Organization,Cellular Function and Maintenance","Organization of keratin intermediate filaments",0.00948,"KRT20",1
"Cell Cycle","Senescence of kidney cells",0.00948,"CYP24A1",1
"Dermatological Diseases and Conditions,Infectious Diseases,Organismal Injury and Abnormalities","Pediculosis capitis",0.00948,"SCN1A",1
"Cancer","Establishment of carcinoma cell lines",0.00948,"FZD9",1
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease","Uterine serous carcinoma",0.00948,"CDH1,CRABP1,GAL,INA,KRT34,KRT81,PI3,VGLL1",8
"Organismal Injury and Abnormalities","Chronic pain",0.00963,"CA6,CA9,GABBR2,OPRK1,SCN1A",5
"Organismal Injury and Abnormalities","Adverse drug reaction",0.00963,"CA6,CA9,GABRP,OPRK1,SLC12A1,UGT1A9 (includes others)",6
"Cardiovascular Disease","Controlled hypertension",0.00982,"CA6,CA9",2
"Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Anterior cruciate ligament rupture",0.00982,"OPRK1,SCN1A",2
"Connective Tissue Disorders,Hereditary Disorder,Inflammatory Disease,Organismal Injury and Abnormalities,Respiratory Disease","Familial idiopathic pulmonary fibrosis",0.00982,"MMP1,SFTPC",2
"Developmental Disorder,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities,Renal and Urological Disease","Inborn error renal tubular transport",0.01,"CA6,CA9,SLC12A1",3
"Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities","Extrapancreatic neuroendocrine tumor",0.01,"C18orf63,C1orf94,CALCB,CARTPT,CCKBR,CDH19,CHGA,CHRDL2,CT83,DDC,DLX6,DNER,FBN3,FETUB,FGA,FZD9,GAL,GLDC,GNGT1,HRCT1,IL36A,KLHL1,LACRT,LCT,LUZP4,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB4,NETO1,NKX2-1,NR2E1,OPRK1,PCDH11X,PGBD5,PXDNL,RGR,S100A8,SCN1A,SH3GL3,SLC12A1,SLC26A9,SLIT1,SMR3A,STRA8,SULT1C3,TAFA4,TBXT,TLX3,TMPRSS4,UGT1A6,UGT1A9 (includes others),UGT2B10,ZP4",55
"Digestive System Development and Function","Development of digestive system",0.0102,"AMTN,FOXA2,GABRP,WNT6",4
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Autosomal dominant epilepsy",0.0102,"GABBR2,GAL,KCNQ2,SCN1A",4
"Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Senile lentigo",0.0106,"FABP7,FADS2,GAL",3
"Cardiovascular Disease,Organismal Injury and Abnormalities","Chronic heart failure",0.0106,"CA6,CA9,SLC12A1",3
"Respiratory Disease","Respiratory depression",0.0106,"GABRP,OPRK1,SCN1A",3
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Early infantile epileptic encephalopathy type 1",0.0111,"KCNQ2,SCN1A",2
"Inflammatory Disease,Ophthalmic Disease,Organismal Injury and Abnormalities","Chronic anterior uveitis",0.0111,"CA6,CA9",2
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease","Benign prostatic hyperplasia",0.0118,"CDH1,GABRP,MMP1",3
"Neurological Disease,Skeletal and Muscular Disorders","Muscle spasm",0.0118,"GABRP,OPRK1,SCN1A",3
"Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities","Endocrine cancer",0.0119,"A2ML1,AARD,ACE2,ACTL8,ACTN2,AFAP1-AS1,AMTN,ANKRD1,BARHL2,BPI,C11orf86,C18orf63,C1orf94,CA6,CA9,CALCB,CASP14,CCKBR,CDH1,CDH19,CDK5R2,CELF4,CHGA,CHODL,CHRDL2,CHRNA9,CLDN6,COL9A3,CP,CPB1,CRABP1,CT83,CYP24A1,CYP27C1,CYP2A6 (includes others),CYP2F1,DDC,DHRS2,DIO1,DLX6,DMRT1,DNER,ELF5,EN1,FADS2,FBN3,FETUB,FGA,FGB,FOXA2,FZD9,GABBR2,GABRP,GAL,GGTLC2,GLDC,GNAT3,HCN4,HORMAD1,HRCT1,IL36A,INA,KCNE5,KCNQ2,KCNV1,KIF1A,KLHL1,KLHL34,KRT20,KRT34,KRT38,KRT6C,KRT75,KRT81,KRT83,KRT85,LACRT,LBP,LCT,LMO1,LUZP4,LY6D,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB1,MAGEB4,MMP1,MSLN,NETO1,NKX1-2,NKX2-1,NR2E1,OPRK1,PADI3,PCDH11X,PCDH8,PCSK1N,PGBD5,POU4F1,PPDPFL,PPP1R14C,PRAME,PRDM13,PRKAG3,PROKR2,PRSS3,PRSS33,PXDNL,RAET1L,RCOR2,RGR,RLBP1,S100A8,SCN1A,SH3GL3,SLC12A1,SLC15A1,SLC1A6,SLC26A9,SLC28A1,SLC39A12,SLC6A17,SLIT1,SMC1B,SMOC1,SMR3A,SOST,SOX11,SPANXB1 (includes others),SPDYC,STRA8,SULT1C3,SVOP,TAFA4,TBXT,TCERG1L,TLX3,TMPRSS4,TRIM15,TRIM43/TRIM43B,UGT1A6,UGT1A9 (includes others),UGT2A3,UGT2B10,UGT2B11,UGT2B28,UGT2B4,VGLL1,WNT6,ZP4",152
"Organismal Injury and Abnormalities,Renal and Urological Disease","Renal impairment",0.0122,"CA6,CA9,CHGA,CHRNA9,GABRP,SCN1A,SLC12A1",7
"Cancer,Organismal Injury and Abnormalities","Cancer",0.0123,"A2ML1,AARD,ACE2,ACTL8,ACTN2,AFAP1-AS1,AMTN,ANKRD1,ART3,BARHL2,BPI,C11orf86,C18orf63,C1orf94,CA6,CA9,CALCB,CARTPT,CASP14,CCKBR,CCL7,CDH1,CDH19,CDK5R2,CELF4,CHGA,CHODL,CHRDL2,CHRNA9,CLDN6,COL9A3,CP,CPB1,CRABP1,CRISP3,CRNN,CSAG2/CSAG3,CT83,CXCL10,CYP24A1,CYP27C1,CYP2A6 (includes others),CYP2F1,DCD,DDC,DHRS2,DIO1,DLK1,DLX6,DMRT1,DNER,ELF5,EN1,FABP7,FADS2,FBN3,FETUB,FGA,FGB,FOXA2,FZD9,GABBR2,GABRP,GAL,GGTLC2,GLDC,GNAT3,GNGT1,GSTA2,HAO1,HCN4,HORMAD1,HRCT1,IL36A,INA,KCNE5,KCNQ2,KCNV1,KIF1A,KLHL1,KLHL34,KRT20,KRT34,KRT38,KRT6C,KRT75,KRT81,KRT83,KRT85,LACRT,LBP,LBX1,LCT,LEMD1,LIN28B,LINC00261,LINC00393,LMO1,LUZP4,LY6D,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB1,MAGEB4,MMP1,MSLN,MUC21,NETO1,NGB,NKX1-2,NKX2-1,NR2E1,OPRK1,PADI3,PCDH11X,PCDH8,PCSK1N,PGBD5,PGPEP1L,PI3,PNMA6E,POU4F1,PPDPFL,PPP1R14C,PRAME,PRDM13,PRKAG3,PROKR2,PRR27,PRSS3,PRSS33,PSAPL1,PXDNL,RAB3B,RAET1L,RCOR2,RGR,RLBP1,ROPN1,S100A2,S100A8,SCHLAP1,SCN1A,SFTA3,SFTPC,SH3GL3,SLC12A1,SLC15A1,SLC1A6,SLC26A9,SLC28A1,SLC39A12,SLC6A17,SLIT1,SMC1B,SMOC1,SMR3A,SOST,SOX11,SPANXB1 (includes others),SPDYC,SPRR1A,SPRR2D,STRA8,SULT1C3,SVOP,TAFA4,TBXT,TCAM1P,TCERG1L,TLX3,TMPRSS4,TMSB15A,TRIM15,TRIM43/TRIM43B,UBD,UGT1A6,UGT1A9 (includes others),UGT2A3,UGT2B10,UGT2B11,UGT2B28,UGT2B4,VGLL1,WNT6,ZFP42,ZNF280A,ZP4",190
"Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Loose anagen hair syndrome",0.0124,"A2ML1,KRT75",2
"Cellular Compromise","Injury of cells",0.0124,"CHGA,PI3",2
"Infectious Diseases,Inflammatory Disease,Ophthalmic Disease,Organismal Injury and Abnormalities","Infectious conjunctivitis",0.0124,"CA6,CA9",2
"Organismal Functions,Organismal Injury and Abnormalities,Tissue Morphology","Closure of wound",0.0124,"FGA,FGB",2
"Digestive System Development and Function,Embryonic Development,Organ Development,Organismal Development","Tooth development",0.0125,"AMTN,GABRP,WNT6",3
"Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Intervertebral disc disorder",0.0125,"COL9A3,OPRK1,SCN1A",3
"Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Chronic skin disorder",0.0134,"CXCL10,KRT6C,PI3,PRSS3,S100A2,S100A8,SPRR1A,SPRR2D",8
"Molecular Transport","Transport of molecule",0.0136,"ACTN2,ANKRD1,CA6,CA9,CARTPT,CDH1,CHGA,CP,FGA,FGB,FOXA2,GAL,HCN4,KCNQ2,KCNV1,LACRT,LBP,NGB,SLC12A1,SLC15A1,SLC1A6,SLC26A9,SLC28A1",23
"Cellular Development,Tissue Development","Differentiation of nervous tissue",0.0137,"CDK5R2,EN1,FOXA2,SOX11",4
"Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders,Tissue Morphology","Ankle fracture",0.0137,"OPRK1,SCN1A",2
"Cancer,Cellular Development,Cellular Growth and Proliferation,Neurological Disease,Organismal Injury and Abnormalities,Tumor Morphology","Proliferation of glioma cells",0.0137,"DLK1,SCHLAP1",2
"Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism","Metabolism of retinol",0.0137,"CYP27C1,RLBP1",2
"Ophthalmic Disease,Organismal Injury and Abnormalities","Acute angle closure glaucoma",0.0137,"CA6,CA9",2
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Hereditary sensory and autonomic neuropathy",0.0137,"DDC,KIF1A",2
"Ophthalmic Disease,Organismal Injury and Abnormalities","Chronic open angle glaucoma",0.0137,"CA6,CA9",2
"Cancer,Organismal Injury and Abnormalities,Respiratory Disease","Lung adenocarcinoma",0.014,"A2ML1,ACE2,ACTN2,CDH1,CYP27C1,DIO1,DLK1,DLX6,DMRT1,FGB,HAO1,KCNQ2,KCNV1,KIF1A,KRT20,KRT38,KRT6C,LINC00261,LUZP4,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB4,MMP1,MUC21,NKX2-1,NR2E1,PCDH11X,PCDH8,PRAME,PXDNL,RCOR2,SCN1A,SH3GL3,SLC39A12,SPANXB1 (includes others),UGT1A9 (includes others),UGT2B11,ZP4",39
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease","Uterine serous papillary cancer",0.0142,"CRABP1,GAL,INA,KRT34,KRT81,PI3,VGLL1",7
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities","Esophageal adenocarcinoma",0.0144,"FADS2,LACRT,LBP,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,PADI3,PROKR2,PXDNL,SCN1A,SLC39A12,STRA8",12
"Molecular Transport","Transport of K+",0.0146,"ACTN2,HCN4,KCNQ2,KCNV1",4
"Cardiovascular System Development and Function,Embryonic Development,Organismal Development,Tissue Development","Angiogenesis of chorioallantoic membrane",0.0152,"BPI,CDH1",2
"Metabolic Disease,Organismal Injury and Abnormalities","Hyperbilirubinemia",0.0152,"UGT1A6,UGT1A9 (includes others)",2
"Hair and Skin Development and Function","Hair growth cycle",0.0152,"GAL,KRT83",2
"Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Pain of joint",0.0152,"OPRK1,SCN1A",2
"Organismal Injury and Abnormalities","Cancer pain",0.0152,"OPRK1,SCN1A",2
"Hematological System Development and Function","Fibrinolysis",0.0152,"FGA,FGB",2
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response","Binding of neutrophils",0.0153,"CXCL10,FGA,S100A8",3
"Gastrointestinal Disease,Organismal Injury and Abnormalities","Benign oral disorder",0.0154,"AMTN,CDH1,CRNN,CXCL10,GABRP,MMP1,OPRK1,PRSS33,SCN1A,SPRR1A,SPRR2D,UBD",12
"Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism","Steroid metabolism",0.0155,"CYP24A1,CYP2A6 (includes others),UGT1A9 (includes others),UGT2B11,UGT2B28,UGT2B4",6
"Cardiovascular System Development and Function,Hematological System Development and Function","Blood pressure",0.0161,"ACE2,CARTPT,CHGA",3
"Connective Tissue Disorders,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders,Tissue Morphology","Femoral fracture",0.0167,"OPRK1,SCN1A",2
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Spinocerebellar ataxia type 2",0.0167,"SCN1A,SLC1A6",2
"Post-Translational Modification","Cross-linkage of peptide",0.0167,"PI3,SPRR1A",2
"Organismal Injury and Abnormalities","Fibrin clot",0.0167,"FGA,FGB",2
"Organismal Injury and Abnormalities,Renal and Urological Disease","Renal colic",0.0167,"OPRK1,SCN1A",2
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Spinocerebellar ataxia type 7",0.0167,"SCN1A,SLC1A6",2
"Cardiovascular Disease","Mild hypertension",0.0167,"CA6,CA9",2
"Organismal Injury and Abnormalities","Critical illness",0.0167,"CHRNA9,GABRP,SCN1A,SLC12A1",4
"Cancer,Organismal Injury and Abnormalities","Mesothelioma",0.017,"CDH1,KRT20,MSLN,MUC21,NKX2-1",5
"Endocrine System Disorders,Organismal Injury and Abnormalities,Reproductive System Disease","Polycystic ovary syndrome",0.017,"CA6,CA9,NFE4,S100A8,SCN1A",5
"Endocrine System Disorders,Gastrointestinal Disease,Organismal Injury and Abnormalities","Pancreatic dysplasia",0.017,"CCKBR,CYP2F1,KLHL1,MUC21,OPRK1,UGT1A6,UGT1A9 (includes others)",7
"Dermatological Diseases and Conditions,Immunological Disease,Inflammatory Disease,Organismal Injury and Abnormalities","Lichen planus",0.0173,"DCD,FADS2,S100A2,S100A8",4
"Respiratory Disease","Acute respiratory disorder",0.0178,"ACE2,BPI,CA6,CA9,CHRNA9,CXCL10,GABRP,SCN1A,SLC12A1",9
"Embryonic Development,Organismal Development","Development of body trunk",0.018,"ACTN2,ANKRD1,CDH1,EN1,FABP7,FOXA2,TBXT",7
"Cell-To-Cell Signaling and Interaction,Molecular Transport,Small Molecule Biochemistry","Uptake of neurotransmitter",0.0182,"RAB3B,SLC1A6",2
"Cell Death and Survival","Cell viability of epithelial cells",0.0182,"EN1,UBD",2
"Cell-To-Cell Signaling and Interaction,Hematological System Development and Function,Immune Cell Trafficking,Inflammatory Response","Aggregation of phagocytes",0.0182,"CDH1,S100A8",2
"Cardiovascular Disease","Stage II systolic hypertension",0.0182,"CA6,CA9",2
"Cardiovascular Disease","Childhood hypertension",0.0182,"CA6,CA9",2
"Organismal Injury and Abnormalities","Wound",0.0185,"FGA,FGB,SFTA3",3
"Neurological Disease,Organismal Injury and Abnormalities","Cluster headache",0.0185,"CA6,CA9,SCN1A",3
"Neurological Disease,Organismal Injury and Abnormalities","Childhood encephalopathy",0.0186,"CA6,CA9,GABBR2,KCNQ2,RLBP1,SCN1A",6
"Cancer,Organismal Injury and Abnormalities","Malignant solid tumor",0.0187,"A2ML1,AARD,ACE2,ACTL8,ACTN2,AFAP1-AS1,AMTN,ANKRD1,ART3,BARHL2,BPI,C11orf86,C18orf63,C1orf94,CA6,CA9,CALCB,CARTPT,CASP14,CCKBR,CCL7,CDH1,CDH19,CDK5R2,CELF4,CHGA,CHODL,CHRDL2,CHRNA9,CLDN6,COL9A3,CP,CPB1,CRABP1,CRISP3,CRNN,CT83,CXCL10,CYP24A1,CYP27C1,CYP2A6 (includes others),CYP2F1,DCD,DDC,DHRS2,DIO1,DLK1,DLX6,DMRT1,DNER,ELF5,EN1,FABP7,FADS2,FBN3,FETUB,FGA,FGB,FOXA2,FZD9,GABBR2,GABRP,GAL,GGTLC2,GLDC,GNAT3,GNGT1,GSTA2,HAO1,HCN4,HORMAD1,HRCT1,IL36A,INA,KCNE5,KCNQ2,KCNV1,KIF1A,KLHL1,KLHL34,KRT20,KRT34,KRT38,KRT6C,KRT75,KRT81,KRT83,KRT85,LACRT,LBP,LBX1,LCT,LEMD1,LIN28B,LINC00261,LINC00393,LMO1,LUZP4,LY6D,LYZL1,MAGEA3/MAGEA6,MAGEA4,MAGEA9/MAGEA9B,MAGEB1,MAGEB4,MMP1,MSLN,MUC21,NETO1,NGB,NKX1-2,NKX2-1,NR2E1,OPRK1,PADI3,PCDH11X,PCDH8,PCSK1N,PGBD5,PGPEP1L,PI3,PNMA6E,POU4F1,PPDPFL,PPP1R14C,PRAME,PRDM13,PRKAG3,PROKR2,PRR27,PRSS3,PRSS33,PSAPL1,PXDNL,RAB3B,RAET1L,RCOR2,RGR,RLBP1,ROPN1,S100A2,S100A8,SCHLAP1,SCN1A,SFTA3,SFTPC,SH3GL3,SLC12A1,SLC15A1,SLC1A6,SLC26A9,SLC28A1,SLC39A12,SLC6A17,SLIT1,SMC1B,SMOC1,SMR3A,SOST,SOX11,SPANXB1 (includes others),SPDYC,SPRR1A,SPRR2D,STRA8,SULT1C3,SVOP,TAFA4,TBXT,TCAM1P,TCERG1L,TLX3,TMPRSS4,TMSB15A,TRIM15,TRIM43/TRIM43B,UBD,UGT1A6,UGT1A9 (includes others),UGT2A3,UGT2B10,UGT2B11,UGT2B28,UGT2B4,VGLL1,WNT6,ZFP42,ZNF280A,ZP4",189
"Cancer,Organismal Injury and Abnormalities","Genitourinary carcinoma",0.0187,"A2ML1,AARD,ACE2,ACTN2,ANKRD1,BARHL2,C1orf94,CA9,CALCB,CCKBR,CCL7,CDH1,CDH19,CELF4,CHGA,CHRNA9,CLDN6,COL9A3,CP,CPB1,CRABP1,CRNN,CXCL10,CYP24A1,CYP2A6 (includes others),CYP2F1,DCD,DDC,DIO1,DLK1,DLX6,DMRT1,DNER,EN1,FABP7,FADS2,FBN3,FETUB,FGA,FOXA2,FZD9,GABBR2,GABRP,GAL,GLDC,GNGT1,GSTA2,HAO1,HCN4,HORMAD1,HRCT1,IL36A,INA,KCNE5,KCNQ2,KCNV1,KIF1A,KLHL1,KLHL34,KRT20,KRT34,KRT75,KRT81,KRT83,KRT85,LACRT,LCT,LIN28B,LINC00261,LUZP4,LYZL1,MAGEA3/MAGEA6,MAGEA4,MMP1,MSLN,MUC21,NETO1,NKX2-1,NR2E1,OPRK1,PCDH11X,PCDH8,PGBD5,PGPEP1L,PI3,PNMA6E,POU4F1,PRAME,PRDM13,PRKAG3,PROKR2,PRSS3,PSAPL1,PXDNL,RAET1L,RCOR2,RLBP1,ROPN1,S100A2,S100A8,SCN1A,SH3GL3,SLC12A1,SLC15A1,SLC1A6,SLC26A9,SLC28A1,SLC39A12,SLC6A17,SLIT1,SMC1B,SMOC1,SMR3A,SOST,SOX11,SPANXB1 (includes others),SPDYC,STRA8,SULT1C3,TCERG1L,TMPRSS4,TRIM43/TRIM43B,UGT1A6,UGT1A9 (includes others),UGT2B10,UGT2B11,UGT2B28,UGT2B4,VGLL1,WNT6,ZFP42,ZNF280A,ZP4",133
"Cancer,Developmental Disorder,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Stage IV indolent marginal zone cell lymphoma",0.0189,"KRT20",1
"Small Molecule Biochemistry","Metabolism of cisapride",0.0189,"CYP2A6 (includes others)",1
"Cancer,Cellular Response to Therapeutics,Organismal Injury and Abnormalities","Doxorubicin resistance of carcinoma cell lines",0.0189,"CSAG2/CSAG3",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Stage II small B-cell lymphocytic lymphoma",0.0189,"KRT20",1
"Amino Acid Metabolism,Molecular Transport,Small Molecule Biochemistry","Quantity of valine",0.0189,"CA9",1
"Cancer,Developmental Disorder,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Stage III indolent marginal zone cell lymphoma",0.0189,"KRT20",1
"Amino Acid Metabolism","Quantity of asparagine",0.0189,"CA9",1
"Cell Morphology","Elongation of skin cancer cell lines",0.0189,"CDH1",1
"Cardiovascular System Development and Function","Formation of capillary network",0.0189,"CHGA",1
"Connective Tissue Disorders,Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities","Autosomal recessive recessive epidermolysis bullosa dystrophica",0.0189,"MMP1",1
"Tissue Morphology","Quantity of embryonic cancer cell lines",0.0189,"LINC00261",1
"Drug Metabolism,Small Molecule Biochemistry","Metabolism of halothane",0.0189,"CYP2A6 (includes others)",1
"Developmental Disorder,Organismal Injury and Abnormalities,Respiratory Disease","Congenital cystic adenomatoid malformation",0.0189,"CDH1",1
"Organismal Injury and Abnormalities,Respiratory Disease","Respiratory distress syndrome of the newborn",0.0189,"NKX2-1",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Stage III lymphoplasmacytic lymphoma",0.0189,"KRT20",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Grade 1 small B-cell lymphocytic lymphoma",0.0189,"KRT20",1
"Organismal Injury and Abnormalities,Respiratory Disease,Skeletal and Muscular Disorders","Hiccup",0.0189,"GABBR2",1
"Carbohydrate Metabolism,Lipid Metabolism,Molecular Transport,Small Molecule Biochemistry","Transport of lipopolysaccharide",0.0189,"LBP",1
"Neurological Disease,Skeletal and Muscular Disorders","Severe muscle spasticity",0.0189,"GABBR2",1
"Cell Cycle","Entry into S phase of pancreatic cancer cell lines",0.0189,"MSLN",1
"DNA Replication, Recombination, and Repair,Nucleic Acid Metabolism,Small Molecule Biochemistry","Metabolism of thymidine",0.0189,"GLDC",1
"Cellular Movement,Nervous System Development and Function","Guidance of motor axons",0.0189,"SLIT1",1
"Organismal Injury and Abnormalities","Chronic shoulder pain",0.0189,"SCN1A",1
"Cell Morphology","Elongation of colorectal cancer cell lines",0.0189,"CDH1",1
"Cancer,Developmental Disorder,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Grade 1 indolent marginal zone cell lymphoma",0.0189,"KRT20",1
"Cancer","Tumorsphere formation by bladder cancer cell lines",0.0189,"LIN28B",1
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Severe myoclonic epilepsy borderline",0.0189,"SCN1A",1
"Cellular Compromise","Injury of carcinoma cell lines",0.0189,"PI3",1
"Cell-To-Cell Signaling and Interaction,Renal and Urological System Development and Function","Dissociation of kidney cell lines",0.0189,"CCKBR",1
"Drug Metabolism,Small Molecule Biochemistry","Metabolism of nicotine",0.0189,"CYP2A6 (includes others)",1
"Amino Acid Metabolism,Molecular Transport,Small Molecule Biochemistry","Quantity of L-proline",0.0189,"CA9",1
"Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Generalized epilepsy with febrile seizures plus type 1",0.0189,"SCN1A",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities,Tumor Morphology","Progressive lymphoplasmacytic lymphoma",0.0189,"KRT20",1
"Cell-To-Cell Signaling and Interaction","Clustering of colorectal cancer cell lines",0.0189,"CDH1",1
"Developmental Disorder,Gastrointestinal Disease,Hepatic System Disease,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities","Crigler-Najjar syndrome type 1",0.0189,"UGT1A6",1
"Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization","Compaction of stomach cancer cell lines",0.0189,"CDH1",1
"Nucleic Acid Metabolism,Small Molecule Biochemistry","Metabolism of cytosine",0.0189,"GLDC",1
"Cell Cycle,Renal and Urological System Development and Function","Mitogenesis of mesangial cells",0.0189,"CXCL10",1
"Cell-To-Cell Signaling and Interaction,Cellular Assembly and Organization","Formation of cell-matrix contacts",0.0189,"CDH1",1
"Small Molecule Biochemistry","Efficacy of irinotecan",0.0189,"UGT1A9 (includes others)",1
"Neurological Disease","Clonus",0.0189,"GABBR2",1
"Cell Morphology,Hematological System Development and Function,Hematopoiesis","Polarization of hematopoietic progenitor cells",0.0189,"CXCL10",1
"Cell Morphology,Cellular Compromise","Multinucleation of colorectal cancer cell lines",0.0189,"UBD",1
"Cellular Development,Embryonic Development,Organ Development,Organismal Development,Reproductive System Development and Function,Tissue Development","Differentiation of mammary epithelial cells",0.0189,"EN1",1
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease","HER2 non-overexpressing breast carcinoma",0.0189,"MAGEA4",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Grade 2 small B-cell lymphocytic lymphoma",0.0189,"KRT20",1
"Developmental Disorder,Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities,Renal and Urological Disease","Primary hyperoxaluria type I",0.0189,"HAO1",1
"Cell-To-Cell Signaling and Interaction","Aggregation of stomach cancer cell lines",0.0189,"CDH1",1
"Cellular Development","Epithelial-mesenchymal transition of skin cancer cell lines",0.0189,"CDH1",1
"Cell Morphology,Nervous System Development and Function","Innervation",0.0189,"POU4F1",1
"Cancer,Endocrine System Disorders,Organismal Injury and Abnormalities","Nonmedullary thyroid carcinoma type 1",0.0189,"NKX2-1",1
"Cancer,Developmental Disorder,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Grade 2 indolent marginal zone cell lymphoma",0.0189,"KRT20",1
"Molecular Transport,Nucleic Acid Metabolism,Small Molecule Biochemistry","Transport of deoxyuridine",0.0189,"SLC28A1",1
"Drug Metabolism,Endocrine System Development and Function,Lipid Metabolism,Small Molecule Biochemistry","Glucuronidation of testosterone",0.0189,"UGT2B28",1
"Cell Cycle","Entry into S phase of endothelial cell lines",0.0189,"CDH1",1
"Amino Acid Metabolism","Quantity of L-glutamine",0.0189,"CA9",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Stage II lymphoplasmacytic lymphoma",0.0189,"KRT20",1
"Cell-To-Cell Signaling and Interaction,Dermatological Diseases and Conditions,Organismal Injury and Abnormalities","Detachment of corneocytes",0.0189,"PI3",1
"Cell Morphology,Cellular Function and Maintenance","Autophagy of melanoma cell lines",0.0189,"MAGEA3/MAGEA6",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Recurrent chronic lymphocytic leukemia",0.0189,"KRT20",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Grade 2 lymphoplasmacytic lymphoma",0.0189,"KRT20",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Fludarabine and alemtuzumab-refractory chronic lymphocytic leukemia",0.0189,"KRT20",1
"Neurological Disease","Flexor spasm",0.0189,"GABBR2",1
"Cellular Assembly and Organization,Cellular Function and Maintenance","Quantity of cytoneme",0.0189,"CDH1",1
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Benign familial neonatal seizures 2",0.0189,"KCNQ2",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Grade 1 lymphoplasmacytic lymphoma",0.0189,"KRT20",1
"Amino Acid Metabolism,Molecular Transport,Small Molecule Biochemistry","Quantity of L-arginine",0.0189,"CA9",1
"Cellular Development,Embryonic Development","Commitment of mesodermal cells",0.0189,"TRIM15",1
"Developmental Disorder,Hereditary Disorder,Metabolic Disease,Ophthalmic Disease,Organismal Injury and Abnormalities","Hermansky-pudlak syndrome type 3",0.0189,"CP",1
"Amino Acid Metabolism","Quantity of L-tyrosine",0.0189,"CA9",1
"Carbohydrate Metabolism,Lipid Metabolism,Small Molecule Biochemistry","Transmission of lipopolysaccharide",0.0189,"LBP",1
"Cancer,Gastrointestinal Disease,Organismal Injury and Abnormalities","TNM stage III gastric cancer",0.0189,"TMPRSS4",1
"Cancer,Organismal Injury and Abnormalities,Reproductive System Disease","Mixed ductal lobular breast carcinoma in situ",0.0189,"CDH1",1
"Cardiovascular Disease,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Brugada syndrome type 8",0.0189,"HCN4",1
"Lipid Metabolism,Small Molecule Biochemistry,Vitamin and Mineral Metabolism","Catabolism of calcifediol",0.0189,"CYP24A1",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Stage IV lymphoplasmacytic lymphoma",0.0189,"KRT20",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Grade 3A small B-cell lymphocytic lymphoma",0.0189,"KRT20",1
"Cell Morphology,Cellular Development,Cellular Growth and Proliferation","Morphogenesis of melanoma cell lines",0.0189,"CDH1",1
"Auditory Disease,Inflammatory Disease,Organismal Injury and Abnormalities","Nonsyndromic otitis media",0.0189,"A2ML1",1
"Amino Acid Metabolism,Molecular Transport,Small Molecule Biochemistry","Quantity of isoleucine",0.0189,"CA9",1
"Developmental Disorder,Hematological Disease,Hereditary Disorder,Immunological Disease,Organismal Injury and Abnormalities","Congenital hypodysfibrinogenemia",0.0189,"FGA",1
"Dermatological Diseases and Conditions,Developmental Disorder,Hereditary Disorder,Organismal Injury and Abnormalities,Skeletal and Muscular Disorders","Hair/nail type ectodermal dysplasia type 4",0.0189,"KRT85",1
"Cell-To-Cell Signaling and Interaction","Aggregation of melanoma cell lines",0.0189,"CDH1",1
"Small Molecule Biochemistry","Glucuronidation of bilirubin",0.0189,"UGT1A9 (includes others)",1
"Cardiovascular Disease,Organismal Injury and Abnormalities","Sinus-node dysfunction",0.0189,"HCN4",1
"Cell Signaling,Cellular Function and Maintenance,Small Molecule Biochemistry,Vitamin and Mineral Metabolism","Calcium homeostasis of cells",0.0189,"CXCL10",1
"Hereditary Disorder,Metabolic Disease,Organismal Injury and Abnormalities","Coumarin resistance",0.0189,"CYP2A6 (includes others)",1
"Cellular Movement","Scattering of adenocarcinoma cell lines",0.0189,"CDH1",1
"Cancer,Developmental Disorder,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Grade 3A indolent marginal zone cell lymphoma",0.0189,"KRT20",1
"Dermatological Diseases and Conditions,Hereditary Disorder,Organismal Injury and Abnormalities","Focal nonepidermolytic palmoplantar keratoderma type 1",0.0189,"KRT6C",1
"Hair and Skin Development and Function","Catagen",0.0189,"GAL",1
"Drug Metabolism,Small Molecule Biochemistry","Glucuronidation of acetaminophen",0.0189,"UGT1A6",1
"Cellular Development,Nervous System Development and Function,Tissue Development","Differentiation of neural-like cells",0.0189,"EN1",1
"Cellular Development,Tissue Development","Differentiation of hippocampal cells",0.0189,"CDK5R2",1
"Cancer,Endocrine System Disorders,Gastrointestinal Disease,Organismal Injury and Abnormalities","Moderately differentiated malignant pancreatic tumor",0.0189,"CDH1",1
"Drug Metabolism,Molecular Transport,Nucleic Acid Metabolism,Small Molecule Biochemistry","Transport of floxuridine",0.0189,"SLC28A1",1
"Cellular Compromise","Injury of lung cancer cell lines",0.0189,"PI3",1
"Cellular Assembly and Organization,Neurological Disease,Organismal Development,Tissue Development","Delay in formation of amyloid fibrils",0.0189,"SFTPC",1
"Amino Acid Metabolism,Molecular Transport,Small Molecule Biochemistry","Quantity of L-histidine",0.0189,"CA9",1
"Cancer,Developmental Disorder,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Stage II indolent marginal zone cell lymphoma",0.0189,"KRT20",1
"Digestive System Development and Function,Gastrointestinal Disease,Hepatic System Development and Function,Hepatic System Disease,Inflammatory Disease,Inflammatory Response,Organ Development,Organismal Injury and Abnormalities","Granulomatous hepatitis",0.0189,"CCL7",1
"Developmental Disorder,Hereditary Disorder,Neurological Disease,Organismal Injury and Abnormalities","Autosomal recessive mental retardation type 48",0.0189,"SLC6A17",1
"Organismal Development","Secretion of tear",0.0189,"LACRT",1
"Cellular Movement","Cell rolling of squamous cell carcinoma cell lines",0.0189,"LY6D",1
"Cancer,Hematological Disease,Immunological Disease,Organismal Injury and Abnormalities","Grade 3A lymphoplasmacytic lymphoma",0.0189,"KRT20",1
"Cell Morphology,Cellular Development,Cellular Growth and Proliferation","Morphogenesis of breast cancer cell lines",0.0189,"CDH1",1
"Cell Death and Survival,Organismal Injury and Abnormalities,Renal and Urological Disease","Apoptosis of proximal tubule cells",0.0189,"CYP24A1",1
"Cardiovascular Disease,Hematological Disease,Hereditary Disorder,Organismal Injury and Abnormalities","Susceptibility to venous thromboembolism",0.0189,"FGA",1
"Neurological Disease,Organismal Injury and Abnormalities,Psychological Disorders","Post-traumatic stress disorder",0.0189,"CA6,CA9,GABRP,SCN1A",4
